Document:

Exchange and Registration Rights Agreement dated as of June 1, 2011

 Exhibit 4.6 
 EXCHANGE AND REGISTRATION RIGHTS AGREEMENT 
 dated as of June 1,
2011 
 between 
 Barrick Gold Corporation 
 Barrick North America Finance LLC

 and 
 Morgan Stanley & Co. LLC 
 RBC Capital Markets, LLC

 Citigroup Global Markets Inc. 
 J.P. Morgan Securities LLC 
 as Representatives of the several Initial
Purchasers 

 This Exchange and Registration Rights Agreement (this “Agreement”) is made
and entered into as of June 1, 2011, between Barrick Gold Corporation, a corporation organized under the laws of the Province of Ontario (the “Company”), and Barrick North America Finance LLC, a Delaware limited liability
company (“BNAF” and, together with the Company, the “Issuers”), on the one hand, and Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC, as
representatives of the several Initial Purchasers (collectively, the “Initial Purchasers”) named in Schedule I to the Purchase Agreement (as defined below), on the other hand. Pursuant to the Purchase Agreement, the Initial
Purchasers have agreed to purchase, severally and not jointly, (i) the Company’s 1.75% Notes due 2014 (the “2014 Notes”) and 2.90% Notes due 2016 (the “2016 Notes”) and (ii) BNAF’s 4.40% Notes
due 2021 (the “2021 Notes”) and 5.70% Notes due 2041 (the “2041 Notes” and together with the 2014 Notes, the 2016 Notes and the 2021 Notes, the “Notes”). The 2021 Notes and the 2041 Notes are fully
and unconditionally guaranteed by the Company (the “Guarantees”). The Notes and the Guarantees are herein collectively referred to as the “Securities.” 

This Agreement is made pursuant to the Purchase Agreement, dated May 24, 2011 (the “Purchase Agreement”), among the
Issuers and the Initial Purchasers (i) for the benefit of the Initial Purchasers and (ii) for the benefit of the holders from time to time of Transfer Restricted Securities (as defined herein), including the Initial Purchasers. In order to
induce the Initial Purchasers to purchase the Notes, the Issuers have agreed to provide the registration rights set forth in this Agreement. The execution and delivery of this Agreement is a condition to the obligations of the Initial Purchasers set
forth in the Purchase Agreement. 
 The parties hereby agree as follows: 

 

	1.	Certain Definitions. For purposes of this Agreement, the following terms shall have the following respective meanings: 

“Base Interest” shall mean the interest that would otherwise accrue on the Notes under the terms
thereof and the Indenture, without giving effect to the provisions of this Agreement. 
 The term
“broker-dealer” shall mean any broker or dealer registered with the Commission under the Exchange Act. 
 “Canadian Prospectus” means a prospectus of the Issuers included in an Exchange Registration Statement or a Shelf Registration Statement under the MJDS (with such
additions and deletions as are required or permitted under the MJDS) filed and 

 
receipted (or for which a notification of clearance has been obtained) under Ontario Securities Laws. 
 “Closing Date” shall mean the date on which the Securities are initially issued. 
 “Commission” shall mean the United States Securities and Exchange Commission, or any other federal agency at the time administering the Exchange Act or the Securities Act,
whichever is the relevant statute for the particular purpose. 
 “Effective Time,” in
the case of (i) an Exchange Registration, shall mean the time and date as of which the Commission declares the Exchange Registration Statement effective or as of which the Exchange Registration Statement otherwise becomes effective and
(ii) a Shelf Registration, shall mean the time and date as of which the Commission declares the Shelf Registration Statement effective or as of which the Shelf Registration Statement otherwise becomes effective. 

“Electing Holder” shall mean any holder of Transfer Restricted Securities that has
returned a completed and signed Notice and Questionnaire to the Company (or its counsel) in accordance with Section 3(b)(ii) or 3(b)(iii) hereof. 
 “Exchange Act” shall mean the United States Securities Exchange Act of 1934, as amended. 
 “Exchange Offer” shall have the meaning assigned thereto in Section 2(a) hereof. 
 “Exchange Registration” shall have the meaning assigned thereto in Section 3(a) hereof. 

“Exchange Registration Statement” shall have the meaning assigned thereto in Section 2(a)
hereof. 
 “Exchange Securities” shall have the meaning assigned thereto in
Section 2(a) hereof. 
 The term “holder” shall mean the Initial Purchasers and
other persons who acquire Transfer Restricted Securities from time to time (including any successors or assigns), in each case for so long as such person owns any Transfer Restricted Securities;

  
 2 

 
provided that for purposes of any obligation of the Issuer to give notice to any holders, “holder” shall mean the record owner of Transfer Restricted Securities. 

“Indenture” shall mean the Indenture dated as of June 1, 2011 between the Issuers,
Wilmington Trust Company, as Trustee (the “Trustee”), and Citibank, N.A., as indenture agent, as the same shall be amended from time to time. 
 “Initial Purchasers” shall have the meaning ascribed to such term in the first paragraph of this Agreement. 

“MJDS” means the U.S./Canada Multijurisdictional Disclosure System adopted by the
Commission and Canadian securities regulators. 
 “Notice and Questionnaire”
means a Notice of Registration Statement and Selling Securityholder Questionnaire substantially in the form of Exhibit A hereto. 
 “Ontario Securities Laws” shall mean the Securities Act (Ontario) and the rules, regulations and national, multijurisdictional and local instruments and published policy
statements applicable in the province of Ontario. 
 “OSC” means the
Ontario Securities Commission. 
 The term “person” shall mean a corporation,
association, partnership, organization, business, individual, government or political subdivision thereof or governmental agency. 
 “Registration Default” shall have the meaning assigned thereto in Section 2(c) hereof. 

“Registration Expenses” shall have the meaning assigned thereto in Section 4 hereof.

 “Resale Period” shall have the meaning assigned thereto in Section 2(a) hereof.

 “Restricted Holder” shall mean (i) a holder that is an affiliate of an Issuer
within the meaning of Rule 405, (ii) a holder who acquires Exchange Securities outside the 

  
 4 

 
ordinary course of such holder’s business, (iii) a holder who has arrangements or understandings with any person to participate in the Exchange Offer for the purpose of distributing
Exchange Securities and (iv) a holder that is a broker-dealer, but only with respect to Exchange Securities received by such broker-dealer pursuant to an Exchange Offer in exchange for Transfer Restricted Securities acquired by the
broker-dealer directly from the Issuer. 
 “Rule 144,” “Rule
405” and “Rule 415” shall mean, in each case, such rule promulgated under the Securities Act (or any successor provision), as the same shall be amended from time to time. 

“Securities Act” shall mean the United States Securities Act of 1933, as amended. 

“Shelf Registration” shall have the meaning assigned thereto in Section 2(b) hereof.

 “Shelf Registration Statement” shall have the meaning assigned thereto in
Section 2(b) hereof. 
 “Special Interest” shall have the meaning assigned thereto
in Section 2(c) hereof. 
 “Transfer Restricted Securities” shall mean each
Security until: 
 (1) the date on which such Security has been exchanged by a person other than a broker-dealer
for an Exchange Security in the Exchange Offer; 
 (2) following the exchange by a broker-dealer in the Exchange
Offer of a Security for an Exchange Security, the date on which such Exchange Security is sold to a purchaser who receives from such broker-dealer on or prior to the date of such sale a copy of the prospectus contained in the Exchange Registration
Statement; 
 (3) the date on which such Security has been effectively registered under the Securities Act and
disposed of in accordance with the Shelf Registration Statement; or 
 (4) such Security shall cease to be
outstanding. 

  
 4 

 “Trust Indenture Act” shall mean the Trust Indenture
Act of 1939, or any successor thereto, and the rules, regulations and forms promulgated thereunder, all as the same shall be amended from time to time. 
 Unless the context otherwise requires, any reference herein to a “Section” or “clause” refers to a Section or clause, as the case may be, of this Agreement, and the words
“herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision. 

 

	2.	Registration Under the Securities Act. 

 (a) Except as set forth in Section 2(b) below, the Issuers agree to file under the Securities Act on or prior to 180 days after the Closing Date, a registration statement on Form S-4/F-9 (which shall
include a Canadian Prospectus in the form of a base shelf prospectus contemplated by National Instrument 44-102—Shelf Distributions (“National Instrument 44-102”) or a short form prospectus or other appropriate form,
prepared and filed with the OSC) relating to an offer to exchange (such registration statement, the “Exchange Registration Statement”, and such offer, the “Exchange Offer”) (i) any and all of the 2014 Notes and
any and all of the 2016 Notes for a like aggregate principal amount of debt securities issued by the Company and (ii) any and all of the 2021 Notes and any and all of the 2041 Notes for a like aggregate principal amount of debt securities
issued by BNAF and guaranteed by the Company, which debt securities and, in the case of the guarantees of the debt securities issued in exchange for the 2021 Notes and the 2041 Notes, respectively, which guarantees are substantially identical to the
applicable Notes and the applicable Guarantees (and are entitled to the benefits of a trust indenture which is substantially identical to the Indenture or is the Indenture and which has been qualified under the Trust Indenture Act), except that they
have been registered pursuant to an effective registration statement under the Securities Act and do not contain provisions for the additional interest contemplated in Section 2(c) below (such new debt securities, together with the guarantees,
hereinafter called “Exchange Securities”). The Exchange Securities will be issued as evidence of the same continuing indebtedness of the Issuers and will not constitute the creation of new indebtedness. The Issuers agree to use
their respective commercially reasonable efforts to cause the Exchange Registration Statement to become effective under the Securities Act on or prior to 270 days after the Closing Date. Notwithstanding the foregoing, if the Issuers are not then
eligible to file the Exchange Registration Statement or the filing of an Exchange Registration Statement is prohibited by any applicable law or applicable interpretation of the staff of the Commission or the OSC, the Issuers shall then, to the
extent not prohibited by applicable law or applicable interpretation of the staff of the Commission or the OSC, prepare and file an Exchange Registration Statement on Form S-4 or another appropriate form permitting registration of the Transfer
Restricted Securities under the Securities Act and in accordance with the methods of distribution elected by the holders and set forth in the Exchange Registration Statement. The Issuers further agree to use their commercially reasonable efforts to
commence and complete the Exchange Offer on or prior to 60 business days after such registration 

  
 5 

 
statement has become effective, hold the Exchange Offer open for not less than 20 business days and exchange Exchange Securities for all Transfer Restricted Securities that have been properly
tendered and not withdrawn on or prior to the expiration of the Exchange Offer. The Exchange Offer will be deemed to have been “completed” only if the Exchange Securities received by holders other than Restricted Holders in the Exchange
Offer for Transfer Restricted Securities are, upon receipt, transferable by each such holder without restriction under the Securities Act and the Exchange Act and without material restrictions under blue sky or securities laws of a substantial
majority of the States of the United States. The Exchange Offer shall be deemed to have been completed upon the earlier to occur of (i) the Issuers having exchanged the Exchange Securities for all outstanding Transfer Restricted Securities
pursuant to the Exchange Offer and (ii) the Issuers having exchanged, pursuant to the Exchange Offer, Exchange Securities for all Transfer Restricted Securities that have been properly tendered and not withdrawn before the expiration of the
Exchange Offer, which shall be on a date that is not less than 20 business days following the commencement of the Exchange Offer. The Issuers agree (x) to include in the Exchange Registration Statement a prospectus for use in any resales by any
holder of Exchange Securities that is a broker-dealer that has acquired such Transfer Restricted Securities for its own account as a result of market-making activities or other trading activities and not directly from an Issuer, and (y) to keep
such Exchange Registration Statement effective for a period (the “Resale Period”) beginning when Exchange Securities are first issued in the Exchange Offer and ending upon the earlier of the expiration of the 180th day after the Exchange Offer has been completed or such time as such
broker-dealers no longer own any Transfer Restricted Securities, other than Transfer Restricted Securities acquired from an Issuer. With respect to such Exchange Registration Statement, such holders shall have the benefit of the rights of
indemnification and contribution set forth in Sections 6(a), (c), (d) and (e) hereof. 
 (b) If (i) on or prior
to the time the Exchange Offer is completed, existing Commission interpretations are changed such that the debt securities received by holders other than Restricted Holders in the Exchange Offer for Transfer Restricted Securities are not or would
not be, upon receipt, transferable by each such holder without restriction under the Securities Act, (ii) the Exchange Offer has not been completed within the applicable time period set forth in section 2(a) hereof or (iii) the Exchange
Offer is not available to any holder of the Securities in the United States, the Issuers shall, in lieu of (or, in the case of clause (iii), in addition to) conducting the Exchange Offer contemplated by Section 2(a), use their commercially
reasonable efforts to file with the Commission on or prior to 180 days after the time such obligation to file arises, a “shelf” registration statement on Form F-3/F-9 (which shall include a Canadian Prospectus in the form of a base shelf
prospectus contemplated by National Instrument 44-102, prepared and filed with the OSC) or other appropriate form of registration statement providing for the registration of, and the sale on a continuous or delayed basis by the holders of, all of
the Transfer Restricted Securities, pursuant to Rule 415 or any similar rule that may be adopted by the Commission (such filing, the “Shelf Registration” and such registration statement, the “Shelf Registration
Statement”). The Issuers agree to use their commercially reasonable efforts (x) to cause the Shelf Registration Statement to become or be declared effective on or prior to 270 days after such obligation to file arises and to keep such
Shelf Registration Statement 

  
 6 

 
continuously effective for a period ending on the earlier of the first anniversary of the Effective Time or such time as there are no longer any Transfer Restricted Securities outstanding,
provided, however, that no holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement or to use the prospectus forming a part thereof for resales of Transfer Restricted Securities unless such holder is
an Electing Holder, and (y) after the Effective Time of the Shelf Registration Statement, promptly upon the request of any holder of Transfer Restricted Securities that is not then an Electing Holder, to take any action reasonably necessary to
enable such holder to use the prospectus forming a part thereof for resales of Transfer Restricted Securities, including, without limitation, any action necessary to identify such holder as a selling securityholder in the Shelf Registration
Statement, provided, however, that nothing in this clause (y) shall relieve any such holder of the obligation to return a completed and signed Notice and Questionnaire to the Issuers in accordance with Section 3(b)(iii)
hereof. The Issuers further agree to supplement or make amendments to the Shelf Registration Statement, as and when required by the rules, regulations or instructions applicable to the registration form used by the Issuers for such Shelf
Registration Statement or by the Securities Act or rules and regulations thereunder for shelf registration, and the Issuers agree to furnish to each Electing Holder copies of any such supplement or amendment prior to its being used or promptly
following its filing with the Commission. 
 (c) In the event that (i) the Issuers have not filed the Exchange Registration
Statement or Shelf Registration Statement on or prior to the date on which such registration statement is required to be filed pursuant to Section 2(a) or 2(b), respectively, or (ii) such Exchange Registration Statement or Shelf
Registration Statement has not become effective or been declared effective by the Commission on or prior to the date on which such registration statement is required to become or be declared effective pursuant to Section 2(a) or 2(b),
respectively, or (iii) the Exchange Offer has not been completed within 60 business days after the initial effective date of the Exchange Registration Statement relating to the Exchange Offer (if the Exchange Offer is then required to be made),
or (iv) any Exchange Registration Statement or Shelf Registration Statement required by Section 2(a) or 2(b) hereof is filed and declared effective but thereafter ceases to be effective or usable in connection with resales of Transfer
Restricted Securities during the time periods specified herein, or (v) the Issuers require holders to refrain from disposing of their Securities or Exchange Securities under the circumstances described in Section 3(g) and that suspension
period exceeds 45 days in one instance or 90 days in the aggregate during any consecutive 12-month period (each such event referred to in clauses (i) through (v), a “Registration Default” and each period during which a
Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such Registration Default, subject to the provisions of Section 8(b), special interest (“Special
Interest”), in addition to the Base Interest, shall accrue at a per annum rate of 0.25% with respect to the first 90-day period immediately following the occurrence of the first Registration Default. The amount of the Special Interest will
increase by an additional per annum rate of 0.25% with respect to each subsequent 90 day Registration Default Period until all Registration Defaults have been cured, up to a maximum per annum rate of 0.50% for all Registration Defaults. Following
the cure of all Registration Defaults, the accrual of Special Interest will 

  
 7 

 
cease. The Issuers shall pay all Special Interest, if any, in the manner and on the dates specified in the Indenture. 
 (d) The Issuers shall use their commercially reasonable efforts to take all actions necessary or advisable to be taken by them to ensure that the transactions contemplated herein are effected as so
contemplated. Such actions may include amending and supplementing the prospectus and amending the Exchange Registration Statement or Shelf Registration Statement if required by the rules, regulations or instructions applicable to the registration
form used by the Issuers for such Exchange Registration Statement or Shelf Registration Statement. 
 (e) Any reference herein
to a registration statement as of any time shall be deemed to include any document incorporated, or deemed to be incorporated, therein by reference as of such time and any reference herein to any post-effective amendment to a registration statement
as of any time shall be deemed to include any document incorporated, or deemed to be incorporated, therein by reference as of such time. 
  

	3.	Registration Procedures. 

If the Issuers file a registration statement pursuant to Section 2(a) or Section 2(b), the following provisions shall apply:

 (a) In connection with the Issuers’ obligations with respect to the registration of Exchange Securities as contemplated
by Section 2(a) (the “Exchange Registration”), if applicable, the Issuers shall, as soon as practicable (or as otherwise specified): 
 (i) prepare and file with the Commission on or prior to 180 days after the Closing Date, an Exchange Registration Statement on Form S-4/F-9 (which shall include a Canadian Prospectus in the form of a base
shelf prospectus contemplated by National Instrument 44-102 or short form prospectus or other available form, prepared and filed with the OSC) or other appropriate form of registration statement which may be utilized by the Issuers and which shall
permit the Exchange Offer and resales of Exchange Securities by broker-dealers that have not acquired Transfer Restricted Securities directly from the Issuers during the Resale Period to be effected as contemplated by Section 2(a), and use its
commercially reasonable efforts to cause such Exchange Registration Statement to become effective on or prior to 270 days after the Closing Date; 
 (ii) as soon as practicable prepare and file with the Commission such amendments and supplements to such Exchange Registration Statement and the prospectus (which shall include a Canadian Prospectus or
amendment or supplement 

  
 8 

 
thereto as part of the Exchange Registration Statement if filed under the MJDS) included therein as may be necessary to effect and maintain the effectiveness of such Exchange Registration
Statement for the periods and purposes contemplated in Section 2(a) hereof and as may be required by the applicable rules and regulations of the Commission and the instructions applicable to the form of such Exchange Registration Statement, and
promptly provide each broker-dealer holding Exchange Securities not acquired directly from an Issuer with such number of copies of the prospectus included therein (as then amended or supplemented), in conformity in all material respects with the
requirements of the Securities Act and the rules and regulations of the Commission thereunder, as such broker-dealer reasonably may request prior to the expiration of the Resale Period, for use in connection with resales of Exchange Securities;

 (iii) promptly notify each broker-dealer that has requested or, to the knowledge of the Issuers, received
copies of the prospectus included in such registration statement, and confirm such advice in writing, (A) in cases where a broker-dealer has specifically requested such information, when such Exchange Registration Statement or the prospectus
included therein or any prospectus amendment or supplement or post-effective amendment has been filed, (B) with respect to such Exchange Registration Statement or any post-effective amendment, when the same has become effective, (C) in
cases where a broker-dealer has specifically requested such information, any request by the Commission or the OSC for amendments or supplements to such Exchange Registration Statement or prospectus or for additional information, (D) of the
issuance by the Commission of any stop order suspending the effectiveness of such Exchange Registration Statement or the initiation or threatening of any proceedings for that purpose, (E) if at any time the representations and warranties of the
Issuers contemplated by Section 5 cease to be true and correct in all material respects, (F) of the receipt by the Issuers of any notification with respect to the suspension of the qualification of the Exchange Securities for sale in any
jurisdiction or the initiation or threatening of any proceeding for such purpose, or (G) at any time during the Resale Period when a prospectus is required to be delivered under the Securities Act, that such Exchange Registration Statement,
prospectus, prospectus amendment or supplement or post-effective amendment does not conform in all material respects to the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission
thereunder or any applicable Ontario Securities Laws or contains an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the
circumstances then existing; 
 (iv) in the event that the Issuers would be required, pursuant to
Section 3(a)(iii)(G) above, to notify any broker-dealers holding Exchange Securities, without delay prepare and furnish to each such holder a reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered
to purchasers of such Exchange Securities during the Resale Period, such prospectus shall conform in all 

  
 9 

 
material respects to the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and the Ontario Securities Laws, if
applicable, and shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing;

 (v) use their commercially reasonable efforts to obtain the withdrawal of any order suspending the
effectiveness of such Exchange Registration Statement or any post-effective amendment thereto at the earliest practicable date; 
 (vi) use their commercially reasonable efforts to (A) register or qualify (or obtain an exemption from such registration or qualification) the Exchange Securities under the securities laws or blue
sky laws of such jurisdictions in the United States as are contemplated by Section 2(a) no later than the commencement of the Exchange Offer, (B) keep such registrations or qualifications (or the exemptions therefrom) in effect and comply
with such laws so as to permit the continuance of offers, sales and dealings therein in such jurisdictions until the expiration of the Resale Period and (C) take any and all other actions as may be reasonably necessary or advisable to enable
each broker-dealer holding Exchange Securities to consummate the disposition thereof in such jurisdictions; provided, however, that no Issuer shall be required for any such purpose to (1) qualify as a foreign corporation in any jurisdiction
wherein it would not otherwise be required to qualify but for the requirements of this Section 3(a)(vi), (2) consent to general service of process in any such jurisdiction or (3) make any changes to its certificate of incorporation or
by-laws or any agreement between it and its shareholders; 
 (vii) obtain the consent or approval of each
governmental agency or authority, whether federal, state, provincial or local, which may be required to effect the Exchange Registration, the Exchange Offer and the offering and sale of Exchange Securities by broker-dealers during the Resale Period;

 (viii) provide CUSIP numbers for all Exchange Securities, not later than the applicable Effective Time; and

 (ix) comply with all applicable rules and regulations of the Commission and make generally available to its
securityholders as soon as practicable but no later than eighteen months after the effective date of such Exchange Registration Statement, an earning statement of the Company and its subsidiaries complying with Section 11(a) of the Securities
Act (including, at the option of the Company, Rule 158 thereunder). 

  
 10 

 (b) In connection with the Issuers’ obligations with respect to the Shelf Registration,
if applicable, the Issuers shall, as soon as practicable (or as otherwise specified): 
 (i) prepare and file
with the Commission, within the time periods specified in Section 2(b), a Shelf Registration Statement on Form F-3/F-9 (which shall include a Canadian Prospectus in the form of a base shelf prospectus contemplated by National Instrument 44-102,
prepared and filed with the OSC) or other appropriate form of registration statement which may be utilized by the Issuers and which shall register all of the Transfer Restricted Securities for resale by the holders thereof in accordance with such
method or methods of disposition as may be specified by such of the holders as, from time to time, may be Electing Holders and use its commercially reasonable efforts to cause such Shelf Registration Statement to become effective within the time
periods specified in Section 2(b); 
 (ii) not less than 30 calendar days prior to the Effective Time of
the Shelf Registration Statement, mail the Notice and Questionnaire to the holders of Transfer Restricted Securities; provided that no holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement as of
the Effective Time, and no holder shall be entitled to use the prospectus forming a part thereof for resales of Transfer Restricted Securities at any time, unless such holder has returned a completed and signed Notice and Questionnaire to the
Issuers (or their counsel) by the deadline for response set forth therein; and provided, further, that holders of Transfer Restricted Securities shall have at least 28 calendar days from the date on which the Notice and Questionnaire is first
mailed to such holders to return a completed and signed Notice and Questionnaire to the Company (or their counsel); 
 (iii) after the Effective Time of the Shelf Registration Statement, upon the request of any holder of Transfer Restricted Securities that is not then an Electing Holder, promptly send a Notice and
Questionnaire to such holder; provided that the Issuers shall not be required to take any action to name such holder as a selling securityholder in the Shelf Registration Statement or to enable such holder to use the prospectus forming a part
thereof for resales of Transfer Restricted Securities until 30 days after such holder has returned a completed and signed Notice and Questionnaire to the Issuers (or their counsel); 

(iv) as soon as practicable prepare and file with the Commission and, if applicable, the OSC such amendments and
supplements to such Shelf Registration Statement and the prospectus (which shall include a Canadian Prospectus as part of the Exchange Registration Statement if filed under the MJDS) included therein as may be necessary to effect and maintain the
effectiveness of such Shelf Registration Statement for the period specified in Section 2(b) hereof and as may be required by the applicable 

  
 11 

 
rules and regulations of the Commission and the OSC and the instructions applicable to the form of such Shelf Registration Statement, and furnish to the Electing Holders copies of any such
supplement or amendment simultaneously with or prior to its being used or filed with the Commission and the OSC; 
 (v) comply with the provisions of the Securities Act and any applicable Ontario Securities Laws with respect to the disposition of all of the Transfer Restricted Securities covered by such Shelf
Registration Statement in accordance with the intended methods of disposition by the Electing Holders provided for in such Shelf Registration Statement; 
 (vi) provide (A) any Electing Holders, (B) the underwriters (which term, for purposes of this Agreement, shall include a person deemed to be an underwriter within the meaning of
Section 2(a)(11) of the Securities Act), if any, thereof, (C) any sales or placement agent therefor, (D) counsel for any such underwriter or agent and (E) not more than one counsel for all the Electing Holders, the opportunity to
review and provide comments in connection with the preparation of such Shelf Registration Statement, each prospectus included therein or filed with the Commission or, if applicable, the OSC and each amendment or supplement thereto; 

(vii) for a reasonable period prior to the filing of such Shelf Registration Statement, and throughout the period
specified in Section 2(b), make available during reasonable business hours at the Issuers’ principal places of business or such other reasonable place for inspection by the persons referred to in Section 3(b)(vi) such financial and
other information and books and records of the Issuers, and cause the officers, employees, counsel and independent chartered accountants of the Issuers to respond to such inquiries, as shall be reasonably necessary, in the judgment of the respective
counsel referred to in such Section, to conduct a reasonable investigation within the meaning of Section 11 of the Securities Act; provided, however, that each such party shall be required to agree in writing to maintain in confidence
and not to disclose to any other person any information or records reasonably designated by the Issuers as being confidential, until such time as (A) such information becomes a matter of public record (whether by virtue of its inclusion in such
Shelf Registration Statement or otherwise), or (B) such person shall be required to disclose such information pursuant to a subpoena or order of any court or other governmental agency or body having jurisdiction over the matter (subject to the
requirements of such order, and only after such person shall have given the Issuers prompt prior written notice of such requirement); 
 (viii) promptly notify each of the Electing Holders, any sales or placement agent therefor and any underwriter thereof (which notification may be made through any managing underwriter that is a
representative of such underwriter for such purpose) and 

  
 12 

 
confirm such advice in writing, (A) when such Shelf Registration Statement or the prospectus included therein or any prospectus amendment or supplement or post-effective amendment has been
filed with the Commission or the OSC, and, with respect to such Shelf Registration Statement or any post-effective amendment, when the same has become effective, (B) in cases where an Electing Holder has specifically requested such information
in writing, of any comments by the Commission and by the blue sky or securities commissioner or regulator of any state or province with respect thereto or any request by the Commission for amendments or supplements to such Shelf Registration
Statement or prospectus or for additional information, (C) of the issuance by the Commission of any stop order suspending the effectiveness of such Shelf Registration Statement or the initiation or threatening of any proceedings for that
purpose, (D) if at any time the representations and warranties of the Issuers contemplated by Section 3(b)(xvii) or Section 5 cease to be true and correct in all material respects, (E) of the receipt by the Issuers of any
notification with respect to the suspension of the qualification of the Transfer Restricted Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, or (F) if at any time when a prospectus is
required to be delivered under the Securities Act or Ontario Securities Laws, that such Shelf Registration Statement, prospectus, prospectus amendment or supplement or post-effective amendment does not conform in all material respects to the
applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder or any applicable Ontario Securities Laws or contains an untrue statement of a material fact or omits to state any
material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing; 
 (ix) use its commercially reasonable efforts to obtain the withdrawal of (A) any order suspending the effectiveness of such Shelf Registration Statement or any post-effective amendment thereto at the
earliest practicable date or (B) the suspension of the qualification of the Transfer Restricted Securities for sale in any jurisdiction; 
 (x) if requested by any managing underwriter or underwriters, any placement or sales agent or any Electing Holder, promptly incorporate in a prospectus supplement or post-effective amendment such
information as is required by the applicable rules and regulations of the Commission or, if applicable, the OSC and as such managing underwriter or underwriters, such agent or such Electing Holder specifies should be included therein relating to the
terms of the sale of such Transfer Restricted Securities, including information with respect to the principal amount of Transfer Restricted Securities being sold by such Electing Holder or agent or to any underwriters, the name and description of
such Electing Holder, agent or underwriter, the offering price of such Transfer Restricted Securities and any discount, commission or other compensation payable in respect thereof, the purchase price being paid therefor by such underwriters and with
respect to any other terms of the offering of the Transfer Restricted Securities to be sold by such Electing Holder or agent or to such underwriters; and make all required 

  
 13 

 
filings of such prospectus supplement or post-effective amendment promptly after notification of the matters to be incorporated in such prospectus supplement or post-effective amendment;

 (xi) furnish to each Electing Holder, each placement or sales agent, if any, therefor, each underwriter, if
any, thereof and the respective counsel referred to in Section 3(b)(vi) an executed copy (or, in the case of an Electing Holder, a conformed copy) of such Shelf Registration Statement, each such amendment and supplement thereto (in each case
including all exhibits thereto (in the case of an Electing Holder of Transfer Restricted Securities, upon request) and documents incorporated by reference therein) and such number of copies of such Shelf Registration Statement (excluding exhibits
thereto and documents incorporated by reference therein unless specifically so requested by such Electing Holder, agent or underwriter, as the case may be) and of the prospectus included in such Shelf Registration Statement (including each
preliminary prospectus and any summary prospectus), in conformity in all material respects with the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and any
applicable Ontario Securities Laws, and such other documents, as such Electing Holder, agent, if any, and underwriter, if any, may reasonably request in order to facilitate the offering and disposition of the Transfer Restricted Securities owned by
such Electing Holder, offered or sold by such agent or underwritten by such underwriter and to permit such Electing Holder, agent and underwriter to satisfy the prospectus delivery requirements of the Securities Act and any applicable Ontario
Securities Laws; and the Issuers hereby consent to the use of such prospectus (including such preliminary and summary prospectus) and any amendment or supplement thereto by each such Electing Holder and by any such agent and underwriter, in each
case in the form most recently provided to such person by the Issuers, in connection with the offering and sale of the Transfer Restricted Securities covered by the prospectus (including such preliminary and summary prospectus) or any supplement or
amendment thereto; 
 (xii) use their commercially reasonable efforts to (A) register or qualify (or obtain
an exemption from such registration or qualification) the Transfer Restricted Securities to be included in such Shelf Registration Statement under such securities laws or blue sky laws of such jurisdictions in the United States as any Electing
Holder and each placement or sales agent, if any, therefor and underwriter, if any, thereof shall reasonably request and ensure that any Transfer Restricted Securities can be offered in a private placement in the provinces of Ontario and Quebec if
any Electing Holders are resident in the province of Ontario or Quebec, as applicable, (B) keep such registrations or qualifications (or the exemptions therefrom) in effect and comply with such laws so as to permit the continuance of offers,
sales and dealings therein in such jurisdictions during the period the Shelf Registration is required to remain effective under Section 2(b) above and for so long as may be necessary to enable any such Electing Holder, agent or underwriter to
complete its distribution of Securities pursuant to such Shelf Registration 

  
 14 

 
Statement and (C) take any and all other actions as may be reasonably necessary or advisable to enable each such Electing Holder, agent, if any, and underwriter, if any, to consummate the
disposition in such jurisdictions of such Transfer Restricted Securities; provided, however, that no Issuer shall be required for any such purpose to (1) qualify as a foreign corporation in any jurisdiction wherein it would not otherwise
be required to qualify but for the requirements of this Section 3(b)(xii), (2) consent to general service of process in any such jurisdiction, or (3) make any changes to its constating documents or by-laws or any agreement between it
and its shareholders; 
 (xiii) use their commercially reasonable efforts to obtain the consent or approval of
each governmental agency or authority, whether federal or state, which may be required to effect the Shelf Registration or the offering or sale in connection therewith or to enable the selling holder or holders to offer, or to consummate the
disposition of, their Transfer Restricted Securities in the United States; 
 (xiv) unless any Transfer
Restricted Securities shall be in book-entry only form, cooperate with the Electing Holders and the managing underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Transfer Restricted Securities to be
sold, which certificates, if so required by any securities exchange upon which any Transfer Restricted Securities are listed, shall be penned, lithographed or engraved, or produced by any combination of such methods, on steel engraved borders, and
which certificates shall not bear any restrictive legends (unless such Transfer Restricted Securities are held by Electing Holders resident in the province of Ontario or Quebec); and, in the case of an underwritten offering, enable such Transfer
Restricted Securities to be in such denominations and registered in such names as the managing underwriters may request at least two business days prior to any sale of the Transfer Restricted Securities; 

(xv) provide CUSIP numbers for all Transfer Restricted Securities, not later than the applicable Effective Time;

 (xvi) enter into one or more underwriting agreements, engagement letters, agency agreements, “best
efforts” underwriting agreements or similar agreements, as appropriate, including customary provisions relating to indemnification and contribution, and take such other actions in connection therewith as any Electing Holders aggregating at
least a majority in aggregate principal amount of the Transfer Restricted Securities at the time outstanding shall request in order to expedite or facilitate the disposition of such Transfer Restricted Securities in the United States; provided that
the Issuers shall not be required to enter into any such agreement more than twice with respect to all of the Transfer Restricted Securities and may delay entering into any such agreement until the

  
 15 

 
consummation of any underwritten public offering in which the Issuers shall be engaged provided that such delay is reasonable; 

(xvii) whether or not an agreement of the type referred to in Section 3(b)(xvi) hereof is entered into and whether
or not any portion of the offering contemplated by the Shelf Registration is an underwritten offering or is made through a placement or sales agent or any other entity, (A) make such representations and warranties to the Electing Holders and
the placement or sales agent, if any, therefor and the underwriters, if any, thereof in form, substance and scope as are customarily made in connection with an offering of debt securities pursuant to any appropriate agreement or to a registration
statement filed on the form applicable to the Shelf Registration; (B) use commercially reasonable efforts to obtain opinions of counsel to the Issuers in customary form and covering such matters, of the type customarily covered by such an
opinion as the managing underwriters, if any, or as any Electing Holders of at least a majority in aggregate principal amount of the Transfer Restricted Securities at the time outstanding may reasonably request, addressed to such Electing Holder or
Electing Holders and the placement or sales agent, if any, therefor and the underwriters, if any, thereof and dated the effective date of such Shelf Registration Statement (and if such Shelf Registration Statement contemplates an underwritten
offering of a part or all of the Transfer Restricted Securities, dated the date of the closing under the underwriting agreement relating thereto); (C) use commercially reasonable efforts to obtain a “cold comfort” letter or letters
from the independent chartered accountants of the Company (and the independent chartered accountants of any other entity, to the extent that financial statements of such other entity (or pro forma financial statements which include financial
information relating to such other entity) are included or incorporated by reference in the Shelf Registration Statement) addressed to the selling Electing Holders, the placement or sales agent, if any, therefor or the underwriters, if any, thereof,
dated (i) the effective date of such Shelf Registration Statement and (ii) the effective date of any prospectus supplement to the prospectus included in such Shelf Registration Statement or post-effective amendment to such Shelf
Registration Statement which includes unaudited or audited financial statements as of a date or for a period subsequent to that of the latest such statements included in such prospectus (and, if such Shelf Registration Statement contemplates an
underwritten offering pursuant to any prospectus supplement to the prospectus included in such Shelf Registration Statement or post-effective amendment to such Shelf Registration Statement which includes unaudited or audited financial statements as
of a date or for a period subsequent to that of the latest such statements included in such prospectus, dated the date of the closing under the underwriting agreement relating thereto), such letter or letters to be in customary form and covering
such matters of the type customarily covered by letters of such type; (D) deliver such documents and certificates, including officers’ certificates, as may be reasonably requested by any Electing Holders of at least a majority in aggregate
principal amount of the Transfer Restricted Securities at the time outstanding or the placement or sales agent, if any, therefor and the managing underwriters, if any, thereof to evidence the accuracy of

  
 16 

 
the representations and warranties made pursuant to clause (A) above or those contained in Section 5(a) hereof and the compliance with or satisfaction of any agreements or conditions
contained in the underwriting agreement or other agreement entered into by the Issuers; and (E) undertake such obligations relating to expense reimbursement, indemnification and contribution as are provided in Section 6 hereof; 

(xviii) notify in writing each holder of Transfer Restricted Securities of any proposal by the Issuers to amend or waive
any provision of this Agreement pursuant to Section 8(h) hereof and of any amendment or waiver effected pursuant thereto, each of which notices shall contain the text of the amendment or waiver proposed or effected, as the case may be;

 (xix) in the event that any broker-dealer registered under the Exchange Act shall underwrite any Transfer
Restricted Securities or participate as a member of an underwriting syndicate or selling group or “assist in the distribution” (within the meaning of the Conduct Rules (the “Conduct Rules”) of the Financial Industry
Regulatory Authority, Inc. (“FINRA”) or any successor thereto, as amended from time to time) thereof, whether as a holder of such Transfer Restricted Securities or as an underwriter, a placement or sales agent or a broker or dealer
in respect thereof, or otherwise, assist such broker-dealer in complying with the requirements of such Conduct Rules, including by (A) if such Conduct Rules shall so require, engaging a “qualified independent underwriter” (as defined
in such Conduct Rules) to participate in the preparation of the Shelf Registration Statement relating to such Transfer Restricted Securities and to exercise usual standards of due diligence in respect thereto, (B) indemnifying any such
qualified independent underwriter to the extent of the indemnification of underwriters provided in Section 6 hereof (or to such other customary extent as may be requested by such underwriter), and (C) providing such information to such
broker-dealer as may be required in order for such broker-dealer to comply with the requirements of the Conduct Rules; and 
 (xx) comply with all applicable rules and regulations of the Commission, and make generally available to its securityholders as soon as practicable but in any event not later than eighteen months after
the effective date of such Shelf Registration Statement, an earning statement of the Company and its subsidiaries complying with Section 11(a) of the Securities Act (including, at the option of the Company, Rule 158 thereunder). 

(c) In the event that the Issuers would be required, pursuant to Section 3(a)(iii)(G) or Section 3(b)(viii)(F) above, to
notify, as applicable, each broker-dealer, the Electing Holders, the placement or sales agent, if any, therefor and the managing underwriters, if any, thereof, the Issuers shall without delay prepare and furnish to each of the Electing Holders, to
each placement or sales agent, if any, and to each such underwriter, if any, a reasonable number of 

  
 17 

 
copies of a prospectus supplemented or amended so that, as thereafter delivered to purchasers of Transfer Restricted Securities, such prospectus shall conform in all material respects to the
applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and any applicable Ontario Securities Laws and shall not contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. Each Electing Holder agrees that upon receipt of any notice from the Issuers pursuant to
Section 3(a)(iii)(G) or Section 3(b)(viii)(F) hereof, such broker-dealer, Electing Holder, underwriter or placement or sales agent shall forthwith discontinue the disposition of Transfer Restricted Securities pursuant to the Exchange
Registration Statement or the Shelf Registration Statement applicable to such Transfer Restricted Securities until such broker-dealer, Electing Holder, underwriter or placement or sales agent shall have received copies of such amended or
supplemented prospectus and if so directed by the Company, such broker-dealer, Electing Holder, underwriter or placement or sales agent shall destroy or deliver to the Issuers (at the Issuers’ expense) all copies, other than permanent file
copies, then in such Electing Holder’s possession of the prospectus covering such Transfer Restricted Securities at the time of receipt of such notice. 
 (d) In the event of a Shelf Registration, in addition to the information required to be provided by each Electing Holder in its Notice Questionnaire, the Issuers may require such Electing Holder to
furnish to the Issuers such additional information regarding such Electing Holder and such Electing Holder’s intended method of distribution of Transfer Restricted Securities as may be required in the reasonable judgment of counsel for the
Issuers in order to comply with the Securities Act. Each such Electing Holder agrees to notify the Issuers as promptly as practicable of any inaccuracy or change in information previously furnished by such Electing Holder to the Issuers or of the
occurrence of any event in either case as a result of which any prospectus relating to such Shelf Registration contains or would contain an untrue statement of a material fact regarding such Electing Holder or such Electing Holder’s intended
method of disposition of such Transfer Restricted Securities or omits or would omit to state any material fact regarding such Electing Holder or such Electing Holder’s intended method of disposition of such Transfer Restricted Securities
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and promptly to furnish to the Issuers any additional information required to correct and update any previously
furnished information or required so that such prospectus shall not contain, with respect to such Electing Holder or the disposition of such Transfer Restricted Securities, an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. 
 (e) As a condition to its participation in the Exchange Offer pursuant to the terms of this Agreement, each holder of Transfer Restricted Securities shall furnish, upon the request of the Issuers, prior
to the completion of the Exchange Offer, a written representation to the Issuers to the effect that (A) it is not an affiliate of the Issuers, (B) it is not engaged in, and does not intend to engage in, and has no arrangement or
understanding with any person to participate in, a 

  
 18 

 
distribution of the Exchange Securities to be issued in the Exchange Offer and (C) it is acquiring the Exchange Securities in its ordinary course of business, and such holder shall make such
other written representations as the Issuers may reasonably request in order to comply with applicable Ontario Securities Laws. As a condition to its participation in the Exchange Offer pursuant to the terms of this Agreement, each holder shall
acknowledge and agree that any broker-dealer and any such holder using the Exchange Offer to participate in a distribution of the securities to be acquired in the Exchange Offer (1) could not under Commission policy as in effect on the date of
this Agreement rely on the position of the Commission enunciated in Morgan Stanley and Co., Inc. (available June 5, 1991) and Exxon Capital Holdings Corporation (available May 13, 1988), as interpreted in the Commission’s letter to
Shearman & Sterling dated July 2, 1993, and similar no-action letters and (2) must comply with the registration and prospectus delivery requirements of the Securities Act in connection with a secondary resale transaction and that
such a secondary resale transaction must be covered by an effective registration statement containing the selling security holder information required by Item 507 or 508, as applicable, of Regulation S-K if the resales are of Exchange
Securities obtained by such holder in exchange for Securities acquired by such holder directly from the Issuers. 
 (f) Until
the expiration of one year after the Closing Date, the Issuers will not, and will not permit any of their “affiliates” (as defined in Rule 144) to, resell any of the Securities that have been reacquired by any of them except pursuant to an
effective registration statement under the Securities Act. 
 (g) By its acquisition of Securities or Exchange Securities each
Electing Holder and each broker-dealer agrees that, upon the Issuers providing notice to such Electing Holder or broker-dealer or the underwriter or placement or sales agent, as the case may be, (x) of the happening of any event of the kind
described in clauses (C), (D) or (G) of Section 3(a)(iii) hereof or clauses (B), (C) or (F) of Section 3(b)(viii) hereof, or (y) that the Board of Directors of the Company has resolved that the Issuers have a bona
fide business purpose for doing so, then, upon providing such notice (which shall refer to this Section 3(g)), the Issuers may delay the filing or the effectiveness of the Exchange Registration Statement or the Shelf Registration Statement (if
not then filed or effective, as applicable) and shall not be required to maintain the effectiveness thereof or amend or supplement the Exchange Registration Statement or the Shelf Registration Statement, in all cases, for a period (a “Delay
Period”) expiring upon the earlier to occur of (i) in the case of the immediately preceding clause (x), receipt by such broker-dealer, Electing Holder, underwriter or placement or sales agent of the copies of the supplemented or
amended prospectus contemplated by Section 3(c) hereof or until it is advised in writing by the Issuers pursuant to Section 3(c) hereof that the use of the applicable prospectus may be resumed, and has received copies of any amendments or
supplements thereto or (ii) in the case of the immediately preceding clause (y), the date which is the earlier of (A) the date on which such business purpose ceases to interfere with the Issuers’ obligations to file or maintain the
effectiveness of such Exchange Registration Statement or the Shelf Registration Statement pursuant to this Agreement or (B) 60 days after the Issuers notify the Electing Holders of such good faith determination. The period of effectiveness of
the Exchange Registration Statement 

  
 19 

 
provided for in Section 2(a) above and the Shelf Registration Statement provided for in Section 2(b) shall each be extended by a number of days equal to the number of days during any
Delay Period. No Delay Period shall exceed 45 consecutive days, and there shall not be more than two Delay Periods during any 12-month period. 
  

	4.	Registration Expenses. 

The Issuers agree to bear and to pay or cause to be paid promptly all expenses incident to the Issuers’ performance of or compliance
with this Agreement, including (a) any and all Commission, OSC and FINRA registration, filing and review fees and expenses including reasonable fees and disbursements of counsel for the placement or sales agent or underwriters in connection
with such registration, filing and review, (b) all fees and expenses in connection with the qualification of the Securities for offering and sale under the State securities and blue sky laws referred to in Section 3(b)(xii) hereof and
determination of their eligibility for investment under the laws of such jurisdictions as any managing underwriters or the Electing Holders may designate, including any reasonable fees and disbursements of counsel for the Electing Holders or
underwriters in connection with such qualification and determination, (c) all expenses relating to the preparation, printing, production, distribution and reproduction of each registration statement required to be filed hereunder, each
prospectus included therein or prepared for distribution pursuant hereto, each amendment or supplement to the foregoing, the expenses of preparing the Securities for delivery and the expenses of printing or producing any underwriting agreements,
agreements among underwriters, selling agreements and blue sky or legal investment memoranda and all other documents in connection with the offering, sale or delivery of Securities to be disposed of (including certificates representing the
Securities), (d) messenger, telephone and delivery expenses relating to the offering, sale or delivery of Securities and the preparation of documents referred to in clause (c) above, (e) fees and expenses of the Trustee under the
Indenture, any agent of the Trustee and any counsel for the Trustee and of any collateral agent, security trustee or custodian, (f) internal expenses (including all salaries and expenses of the Company’s officers and employees performing
legal or accounting duties), (g) fees, disbursements and expenses of counsel of the Issuers and independent chartered accountants of the Company and any other applicable chartered accountants (including the expenses of any opinions or
“cold comfort” letters required by or incident to such performance and compliance), (h) fees, disbursements and expenses of any “qualified independent underwriter” engaged pursuant to Section 3(b)(xix) hereof,
(i) reasonable fees, disbursements and expenses of one counsel for the Electing Holders retained in connection with a Shelf Registration, as selected by the Electing Holders of at least a majority in aggregate principal amount of the Transfer
Restricted Securities held by Electing Holders (which counsel shall be reasonably satisfactory to the Company and which counsel may also be counsel for the Initial Purchasers), (j) any fees charged by securities rating services for rating the
Securities, and (k) fees, expenses and disbursements of any other persons, including special experts, retained by the Issuers in connection with such registration (collectively, the “Registration Expenses”). To the extent that
any Registration Expenses are incurred, assumed or paid by any holder of Transfer Restricted Securities or any placement or sales agent therefor or underwriter thereof, the Issuers 

  
 20 

 
shall reimburse such person for the full amount of the Registration Expenses so incurred, assumed or paid promptly after receipt of a request therefor with supporting documentation evidencing the
Registration Expenses. Notwithstanding the foregoing, the holders of the Transfer Restricted Securities being registered shall pay all agency fees and commissions and underwriting discounts and commissions attributable to the sale of such Transfer
Restricted Securities and the fees and disbursements of any counsel or other advisors or experts retained by such holders (severally or jointly), other than the counsel and experts specifically referred to above. 

 

	5.	Representations and Warranties. 

 The Company, as issuer and guarantor, and BNAF, as issuer, represent and warrant to, and agree with, the Initial Purchasers and each of the holders from time to time of Transfer Restricted Securities
that: 
 (a) Each registration statement covering Transfer Restricted Securities and each prospectus (including any preliminary
or summary prospectus) contained therein or furnished pursuant to Section 3(b) or Section 3(a) hereof and any further amendments or supplements to any such registration statement or prospectus, when it becomes effective or is filed with
the OSC and the Commission, as the case may be, and, in the case of an underwritten offering of Transfer Restricted Securities, at the time of the closing under the underwriting agreement relating thereto, will conform in all material respects to
the requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and any applicable Ontario Securities Laws and will not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein in the case of a registration statement, not misleading, and in the case of a prospectus not misleading in light of the circumstances under which they were made;
and at all times subsequent to the Effective Time when a prospectus would be required to be delivered under the Securities Act, other than from (i) such time as a notice has been given to holders of Transfer Restricted Securities pursuant to
Section 3(b)(viii)(F) or Section 3(a)(iii)(G) hereof until (ii) such time as the Issuers furnish an amended or supplemented prospectus pursuant to Section 3(c) or Section 3(a)(iv) hereof, each such registration statement,
and each prospectus (including any summary prospectus) contained therein or furnished pursuant to Section 3(b) or Section 3(a) hereof, as then amended or supplemented, will conform in all material respects to the requirements of the
Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and any applicable Ontario Securities Laws and will not contain an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; provided, however, that this representation and warranty shall not apply to any statements or omissions made in
reliance upon and in conformity with information furnished in writing to the Issuers by a holder of Transfer Restricted Securities or any underwriter or placement agent of any offering described therein expressly for use therein. 

  
 21 

 (b) Any documents incorporated by reference in any prospectus referred to in
Section 5(a) hereof, when they become or became effective or are or were filed with or furnished to the Commission and the OSC, as the case may be, will conform or conformed in all material respects to the requirements of the Securities Act,
the Exchange Act and any applicable Ontario Securities Laws, as applicable, and none of such documents will contain or contained, when filed, an untrue statement of a material fact or will omit or omitted, when filed, to state a material fact
required to be stated therein or necessary to make the statements therein not misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with
information furnished in writing to the Issuers by a holder of Transfer Restricted Securities or any underwriter or placement agent of any offering described therein expressly for use therein. 

(c) The compliance by an Issuer with all of the provisions of this Agreement and the consummation of the transactions herein contemplated
will not conflict with or result in a breach of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which an Issuer or any subsidiary of an
Issuer is a party or by which an Issuer or any subsidiary of an Issuer is bound or to which any of the property or assets of an Issuer or any subsidiary of an Issuer is subject, nor will such action result in any violation of the provisions of the
articles of incorporation or the by-laws or other organizational documents, as applicable, of an Issuer or any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over an Issuer or any subsidiary
of an Issuer or any of its properties and no consent, approval, authorization, order, registration or qualification of or with any such court or governmental agency or body is required for the consummation by the Issuers of the transactions
contemplated by this Agreement, except the registration under the Securities Act of the Transfer Restricted Securities and the Exchange Securities, qualification of the Indenture under the Trust Indenture Act and such consents, approvals,
authorizations, registrations or qualifications as may be required under any applicable Ontario Securities Laws, Canadian federal or provincial corporate law or State securities or blue sky laws in connection with the offering and distribution of
the Transfer Restricted Securities and the Exchange Securities. 
 (d) This Agreement has been duly authorized, executed and
delivered by the Issuers. 
  

	6.	Indemnification. 

 (a)
Indemnification by the Issuers. The Issuers, jointly and severally, will indemnify and hold harmless each of the Initial Purchasers, the holders of Transfer Restricted Securities included in an Exchange Registration Statement, each of the
Electing Holders of Transfer Restricted Securities included in a Shelf Registration Statement and each person who participates as a placement or sales agent or as an underwriter in any offering or sale of such Transfer Restricted Securities against
any losses, claims, damages or liabilities, joint or several, to which 

  
 22 

 
such Initial Purchaser, holder, agent or underwriter may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon: 
 (i) any information or statement contained in any Exchange Registration Statement or
Shelf Registration Statement, as the case may be, furnished by the Company to any such holder, Electing Holder, agent or underwriter, or any amendment or supplement thereto, as the case may be, under which such Transfer Restricted Securities were
registered under the Securities Act, which contains or is alleged to contain an untrue statement of a material fact or omits or is alleged to omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading; or 
 (ii) any information or statement contained in any preliminary, final or summary prospectus, as the case may
be, furnished by the Company to any such holder, Electing Holder, agent or underwriter, or any amendment or supplement thereto, as the case may be, which at the time and in the light of the circumstances under which it was made contains or is
alleged to contain an untrue statement of a material fact or omits or is alleged to omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, 

and will reimburse such Initial Purchaser, such holder, such Electing Holder, such agent and such underwriter for any legal or other
expenses reasonably incurred by them in connection with investigating or defending any such action, loss, claim, damage or liability as such expenses are incurred; provided, however, that the Issuers shall not be liable to any such person in
any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in such registration statement, or preliminary, final or
summary prospectus, or amendment or supplement thereto, in reliance upon and in conformity with written information furnished to the Issuers by such person expressly for use therein. 

(b) Indemnification by the Holders and any Agents and Underwriters. The Issuers may require, as a condition to including any
Transfer Restricted Securities in any registration statement filed pursuant to Section 2(b) hereof and to entering into any underwriting agreement with respect thereto, that the Issuers shall have received an undertaking reasonably satisfactory
to them from the Electing Holder of such Transfer Restricted Securities and from each underwriter named in any such underwriting agreement severally and not jointly, to (i) indemnify and hold harmless the Issuers and all other holders of
Transfer Restricted Securities, against any losses, claims, damages or liabilities to which the Issuers or such other holders of Transfer Restricted Securities may become subject, under the Securities Act, the Ontario Securities Laws or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in such registration statement, or any preliminary,
final or summary prospectus 

  
 23 

 
contained therein or furnished by the Issuers to any such Electing Holder, agent or underwriter, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or
omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Issuers by such Electing Holder, agent or underwriter expressly for use therein, and (ii) reimburse the Issuers for any legal or
other expenses reasonably incurred by the Issuers in connection with investigating or defending any such action or claim as such expenses are incurred; provided, however, that no such Electing Holder shall be required to undertake liability
to any person under this Section 6(b) for any amounts in excess of the dollar amount of the proceeds to be received by such Electing Holder from the sale of such Electing Holder’s Transfer Restricted Securities pursuant to such
registration. 
 (c) Notices of Claims, Etc. In case any proceeding (including any governmental investigation) shall be
instituted involving any person in respect of which indemnity may be sought pursuant to either Section 6(a) or 6(b) above, the indemnified party shall promptly notify the indemnifying party in writing and the indemnifying party, upon request of
the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the fees and disbursements of such
counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the
indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified
party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any
indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all indemnified parties and that all such
fees and expenses shall be reimbursed as they are incurred. The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for
the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party,
effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement (i) includes
an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf
of an indemnified party. 

  
 24 

 (d) Contribution. If for any reason the indemnification provisions contemplated by
Section 6(a) or Section 6(b) are unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying
party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative fault of the
indemnifying party and the indemnified party in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations. The
relative fault of such indemnifying party and indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact
relates to information supplied by such indemnifying party or by such indemnified party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto
agree that it would not be just and equitable if contributions pursuant to this Section 6(d) were determined by pro rata allocation (even if the holders or any agents or underwriters or all of them were treated as one entity for such purpose)
or by any other method of allocation which does not take account of the equitable considerations referred to in this Section 6(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages, or liabilities (or
actions in respect thereof) referred to above shall be deemed to include any legal or other fees or expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the
provisions of this Section 6(d), no holder shall be required to contribute any amount in excess of the amount by which the dollar amount of the proceeds received by such holder from the sale of any Transfer Restricted Securities (after
deducting any fees, discounts and commissions applicable thereto) exceeds the amount of any damages which such holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission, and no
underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Transfer Restricted Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any
damages which such underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The holders’ and any underwriters’ obligations in this Section 6(d) to contribute shall be several in
proportion to the principal amount of Transfer Restricted Securities registered or underwritten, as the case may be, by them and not joint. 
 (e) The obligations of the Issuers under this Section 6 shall be in addition to any liability which the Issuers may otherwise have and shall extend, upon the same terms and conditions, to each
officer, director and partner of each holder, agent and underwriter and each person, if any, who controls any holder, agent or underwriter within the meaning of the Securities Act; and the obligations of the holders and any agents or underwriters
contemplated by this Section 6 shall be in addition to any liability which the respective holder, agent or 

  
 25 

 
underwriter may otherwise have and shall extend, upon the same terms and conditions, to each officer and director of any Issuer (including any person who, with his or her consent, is named in any
registration statement as about to become a director of an Issuer) and to each person, if any, who controls an Issuer within the meaning of the Securities Act. 
  

	7.	Underwritten Offerings. 

(a) Selection of Underwriters. If any of the Transfer Restricted Securities covered by the Shelf Registration are to be sold
pursuant to an underwritten offering, the managing underwriter or underwriters thereof shall be designated by Electing Holders holding at least a majority in aggregate principal amount of the Transfer Restricted Securities to be included in such
offering, provided that such designated managing underwriter or underwriters is or are reasonably acceptable to the Issuers. 

(b) Participation by Holders. Each holder of Transfer Restricted Securities hereby agrees with each other such holder that no such
holder may participate in any underwritten offering hereunder unless such holder (i) agrees to sell such holder’s Transfer Restricted Securities on the basis provided in any underwriting arrangements approved by the persons entitled
hereunder to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements.

  

	8.	Miscellaneous. 

 (a)
No Inconsistent Agreements. The Issuers represent, warrant, covenant and agree that they have not granted, and shall not grant, registration rights with respect to Transfer Restricted Securities or any other securities which would be
inconsistent with the terms contained in this Agreement. 
 (b) Specific Performance. The parties hereto acknowledge that
there would be no adequate remedy at law if the Issuers fail to perform any of their obligations hereunder and that the Initial Purchasers and the holders from time to time of the Transfer Restricted Securities may be irreparably harmed by any such
failure, and accordingly agree that the Initial Purchasers and such holders, in addition to any other remedy to which they may be entitled at law or in equity, shall be entitled to compel specific performance of the obligations of the Issuers under
this Agreement in accordance with the terms and conditions of this Agreement, in any court of the United States or any State thereof having jurisdiction. 

  
 26 

 (c) Notices. All notices, requests, claims, demands, waivers and other communications
hereunder shall be in writing and shall be deemed to have been duly given when delivered by hand, if delivered personally or by courier, or three days after being deposited in the mail (registered or certified mail, postage prepaid, return receipt
requested) as follows: if to the Issuers, to Barrick Gold Corporation, Brookfield Place, TD Canada Trust Tower, Suite 3700, 161 Bay Street, P.O. Box 212, Toronto, Ontario, Canada M5J 2S1, Attention: Vice President and Treasurer (with a copy to the
General Counsel), and if to a holder, to the address of such holder set forth in the security register or other records of the Issuers, or to such other address as the Issuers or any such holder may have furnished to the other in writing in
accordance herewith, except that notices of change of address shall be effective only upon receipt. 
 (d) Parties in
Interest. All the terms and provisions of this Agreement shall be binding upon, shall inure to the benefit of and shall be enforceable by the parties hereto and the holders from time to time of the Transfer Restricted Securities and the
respective successors and assigns of the parties hereto and such holders. In the event that any transferee of any holder of Transfer Restricted Securities shall acquire Transfer Restricted Securities, in any manner, whether by gift, bequest,
purchase, operation of law or otherwise, such transferee shall, without any further writing or action of any kind, be deemed a beneficiary hereof for all purposes and such Transfer Restricted Securities shall be held subject to all of the terms of
this Agreement, and by taking and holding such Transfer Restricted Securities such transferee shall be entitled to receive the benefits of, and be conclusively deemed to have agreed to be bound by all of the applicable terms and provisions of, this
Agreement. If the Issuers shall so request, any such successor, assign or transferee shall agree in writing to acquire and hold the Transfer Restricted Securities subject to all of the applicable terms hereof. 

(e) Survival. The respective indemnities, agreements, representations, warranties and each other provision set forth in this
Agreement or made pursuant hereto shall remain in full force and effect regardless of any investigation (or statement as to the results thereof) made by or on behalf of any holder of Transfer Restricted Securities, any director, officer or partner
of such holder, any agent or underwriter or any director, officer or partner thereof, or any controlling person of any of the foregoing, and shall survive delivery of and payment for the Transfer Restricted Securities pursuant to the Purchase
Agreement and the transfer and registration of Transfer Restricted Securities by such holder and the consummation of an Exchange Offer. 
 (f) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York. 

(g) Headings. The descriptive headings of the several Sections and paragraphs of this Agreement are inserted for convenience only,
do not constitute a part of this Agreement and shall not affect in any way the meaning or interpretation of this Agreement. 

  
 27 

 (h) Entire Agreement; Amendments. This Agreement and the other writings referred to
herein (including the Indenture and the form of Securities) or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to its subject matter. This Agreement supersedes all prior agreements and
understandings between the parties with respect to its subject matter. This Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or
prospectively) only by a written instrument duly executed by the Issuers and the holders of at least a majority in aggregate principal amount of the Transfer Restricted Securities at the time outstanding. Each holder of any Transfer Restricted
Securities at the time or thereafter outstanding shall be bound by any amendment or waiver effected pursuant to this Section 8(h), whether or not any notice, writing or marking indicating such amendment or waiver appears on such Transfer
Restricted Securities or is delivered to such holder. 
 (i) Inspection. For so long as this Agreement shall be in
effect, this Agreement and a complete list of the names and addresses of all the holders of Transfer Restricted Securities shall be made available for inspection and copying on any business day by any holder of Transfer Restricted Securities for
proper purposes only (which shall include any purpose related to the rights of the holders of Transfer Restricted Securities under the Securities, the Indenture and this Agreement) at the offices of the Company at the address thereof set forth in
Section 8(c) above and at the office of the Trustee under the Indenture. 
 (j) Counterparts. This Agreement may be
executed by the parties in counterparts, each of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument. 

(k) Service of Process. Each Issuer (i) agrees that any legal suit, action or proceeding against it brought by any holder,
the Initial Purchasers, any agent or underwriter or by any person who controls any holder, agent or underwriter arising out of or based upon this Agreement or the transactions contemplated hereby may be instituted in any Federal or state court
located in the Borough of Manhattan in the City of New York in the State of New York (“New York Court”), (ii) waives, to the fullest extent it may effectively do so, any objection which it may now or hereafter have to the
laying of venue of any such proceeding and (iii) submits to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding. The Company has appointed CT Corporation System, 111 Eighth Avenue, New York, New York 10011, as
its authorized agent (the “Authorized Agent”) upon whom process may be served in any such legal suit, action or preceding against the Company arising out of or based upon this Agreement or the transactions contemplated hereby which
may be instituted in any New York Court by any holder, Initial Purchaser, agent or underwriter or by any person who controls any holder, Initial Purchaser, agent or underwriter. Such appointment shall be irrevocable. The Company represents and
warrants that the Authorized Agent has agreed to act as such agent for service of process and agrees to take any and all action, including the filing of any and all documents and instruments, that may be necessary to continue such appointment in
full force and effect as aforesaid. Service 

  
 28 

 
of process upon the Authorized Agent and written notice of such service to the Company shall be deemed, in every respect, effective service of process upon the Company. 

(l) Judgment Currency. In respect of any judgment or order given or made for any amount due hereunder that is expressed and paid
in a currency (the “judgment currency”) other than United States dollars, the Issuers shall indemnify each holder, agent or underwriter against any loss incurred by such holder, agent or underwriter as a result of any variation as
between (i) the rate of exchange at which the United States dollar amount is converted into the judgment currency for the purpose of such judgment or order and (ii) the rate of exchange at which a holder, agent or underwriter is able to
purchase United States dollars with the amount of judgment currency actually received by such holder, agent or underwriter. The foregoing indemnity shall constitute a separate and independent obligation of the Issuers and shall continue in full
force and effect notwithstanding any such judgment or order as aforesaid. The term “rate of exchange” shall include any premiums and costs of exchange payable in connection with the purchase of or conversion into United States dollars.

  
 29 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	BARRICK GOLD CORPORATION
		
	By:	 	/s/ Jamie C. Sokalsky
		 	 Name: Jamie C. Sokalsky

Title:   Director

 

			
		
	By:	 	/s/ James W. Mavor
		 	 Name: James W. Mavor

Title:   Vice President and Treasurer

 

			
	BARRICK NORTH AMERICA FINANCE LLC
		
	By:	 	/s/ Jamie C. Sokalsky
		 	 Name: Jamie C. Sokalsky

Title:   Director

 

			
		
	By:	 	/s/ James W. Mavor
		 	 Name: James W. Mavor

Title:   Vice President and Treasurer

  
 30 

 Confirmed and accepted as of the date first above written: 

Morgan Stanley & Co. LLC 
 RBC Capital
Markets, LLC 
 Citigroup Global Markets Inc. 
 J.P. Morgan Securities LLC 
 Acting on behalf of themselves and the several Initial Purchasers

  

			
	By: Morgan Stanley & Co. LLC
		
	By:	 	/s/ Yuri Slyz
	Name:	 	Yuri Slyz
	Title:	 	Executive Director

  

			
	By: RBC Capital Markets, LLC
		
	By:	 	/s/ John M. Sconzo
	Name:	 	John M. Sconzo
	Title:	 	Managing Director

  

			
	By: Citigroup Global Markets Inc.
		
	By:	 	/s/ Brian D. Bednarski
	Name:	 	Brian D. Bednarski
	Title:	 	Managing Director

  

			
	By: J.P. Morgan Securities LLC
		
	By:	 	/s/ Robert Bottamedi
	Name:	 	Robert Bottamedi
	Title:	 	Vice President

  
 31 

 Exhibit A 
 FORM OF INSTRUCTION TO DTC PARTICIPANTS 
 [Date of Mailing]

 URGENT — IMMEDIATE ATTENTION REQUESTED 

DEADLINE FOR RESPONSE: [DATE]a 
 The Depository Trust Company (“DTC”) has identified you as a DTC Participant through which beneficial interests in the [Barrick Gold Corporation][Barrick North American Finance
LLC] (the “Company”) Notes due 20— (the “Securities”) are held. 
 The Company is in the process of registering the Securities under the Securities Act of 1933 for resale by the beneficial owners thereof. In order to have their Securities included in the registration
statement, beneficial owners must complete and return the enclosed Notice of Registration Statement and Selling Securityholder Questionnaire. 

It is important that beneficial owners of the Securities receive a copy of the enclosed materials as soon as possible as their rights to have the
Securities included in the registration statement depend upon their returning the Notice and Questionnaire by [Deadline For Response]. Please forward a copy of the enclosed documents to each beneficial owner that holds interests in the
Securities through you. If you require more copies of the enclosed materials or have any questions pertaining to this matter, please contact Barrick Gold Corporation, Brookfield Place, TD Canada Trust Tower, Suite 3700, 161 Bay Street, P.O. Box 212,
Toronto, Ontario, Canada M5J 2S1, Attention:—. 
  

 

	a 
	 Not less than 28 calendar days from date of mailing 

 FORM OF NOTICE OF REGISTRATION STATEMENT 

and 

SELLING SECURITYHOLDER QUESTIONNAIRE 
 [Date] 
 Reference is hereby made to the Exchange and Registration Rights Agreement (the
“Exchange and Registration Rights Agreement”) among Barrick Gold Corporation (the “Company”) and Barrick North America Finance LLC (“BNAF”, and together with the Company, the
“Issuers”), and the Initial Purchasers named therein. Pursuant to the Exchange and Registration Rights Agreement, the Issuers have filed with the United States Securities and Exchange Commission (the “Commission”) a
registration statement on Form F-3/F-9 or other appropriate form of registration statement (the “Shelf Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the
“Securities Act”), of the 1.75% Notes due 2014 of the Company and the 2.90% Notes due 2016 of the Company and the 4.40% Notes due 2021 of BNAF (the “2021 Notes”) and the 5.70% Notes due 2041 of BNAF (the
“2041 Notes”), the 2021 Notes and the 2041 Notes as guaranteed by the Company (collectively, the “Securities”). A copy of the Exchange and Registration Rights Agreement is attached hereto. All capitalized terms not
otherwise defined herein shall have the meanings ascribed thereto in the Exchange and Registration Rights Agreement. 
 Each beneficial owner of
Transfer Restricted Securities (as defined below) is entitled to have the Transfer Restricted Securities beneficially owned by it included in the Shelf Registration Statement. In order to have Transfer Restricted Securities included in the Shelf
Registration Statement, this Notice of Registration Statement and Selling Securityholder Questionnaire (“Notice and Questionnaire”) must be completed, executed and delivered to the Company’s counsel at the address set forth
herein for receipt ON OR BEFORE [Deadline for Response]. Beneficial owners of Transfer Restricted Securities who do not complete, execute and return this Notice and Questionnaire by such date (i) will not be named as selling
securityholders in the Shelf Registration Statement and (ii) may not use the Prospectus forming a part thereof for resales of Transfer Restricted Securities. 
 Certain legal consequences arise from being named as a selling securityholder in the Shelf Registration Statement and related Prospectus. Accordingly, holders and beneficial owners of Transfer Restricted
Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Shelf Registration Statement and related Prospectus. 

The term “Transfer Restricted Securities” is defined in the Exchange and Registration Rights Agreement. 

  
 2 

 ELECTION 
 The undersigned holder (the “Selling Securityholder”) of Transfer Restricted Securities hereby elects to include in the Shelf Registration Statement the Transfer Restricted Securities
beneficially owned by it and listed below in Item (3). The undersigned, by signing and returning this Notice and Questionnaire, agrees to be bound with respect to such Transfer Restricted Securities by the terms and conditions of this Notice and
Questionnaire and the Exchange and Registration Rights Agreement, including, without limitation, Section 6 of the Exchange and Registration Rights Agreement, as if the undersigned Selling Securityholder were an original party thereto.

 Upon any sale of Transfer Restricted Securities pursuant to the Shelf Registration Statement, the Selling Securityholder will be required to
deliver to the Company and Trustee the Notice of Transfer set forth in Appendix A to the Prospectus and as Exhibit B to the Exchange and Registration Rights Agreement. 
 The Selling Securityholder hereby provides the following information to the Company and represents and warrants that such information is accurate and complete: 

QUESTIONNAIRE 
  

					
	 (1)
	 	(a)	 	Full Legal Name of Selling Securityholder:
			
		 		 	 
			
		 	(b)	 	Full Legal Name of Registered Holder (if not the same as in (a) above) of Transfer Restricted Securities Listed in Item (3) below:
			
		 		 	 
			
		 	(c)	 	Full Legal Name of DTC Participant (if applicable and if not the same as (b) above) Through Which Transfer Restricted Securities Listed in Item (3) below are Held:
			
		 		 	 

  

							
	 (2)
	 		 		 	Address for Notices to Selling Securityholder:
		 		 		 	 
		 		 		 	 
		 		 	Telephone:	 	 
		 		 	Fax:	 	 
		 		 	Contact Person:	 	 
		 		 	Email Address:	 	 

  
 3 

	(3)	Beneficial Ownership of Securities: 

 Except as set forth below in this Item (3), the undersigned does not beneficially own any Securities. 
  

					
			
		 	(a)	 	Principal amount of Transfer Restricted Securities beneficially owned:
			
		 		 	 
			
		 		 	CUSIP No(s). of such Transfer Restricted Securities:
			
		 		 	 
			
		 	(b)	 	Principal amount of Securities other than Transfer Restricted Securities beneficially owned:
			
		 		 	 
			
		 		 	CUSIP No(s). of such other Securities:
			
		 		 	 
			
		 	(c)	 	Principal amount of Transfer Restricted Securities which the undersigned wishes to be included in the Shelf Registration Statement:
			
		 		 	 
			
		 		 	CUSIP No(s). of such Transfer Restricted Securities:
			
		 		 	 

  

	(4)	Beneficial Ownership of Other Securities of the Company: 

 Except as set forth below, the undersigned Selling Securityholder is not the beneficial or registered owner of other securities of the Company, other than the Securities listed above in Item (3).

 State any exceptions here: 
  

	(5)	Relationships with the Company: 

Except as set forth below, neither the undersigned Selling Securityholder nor any of its affiliates, officers, directors or principal
equity holders (5% or more) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years. 

State any exceptions here: 

  
 4 

	(6)	Plan of Distribution: 

Except as set forth below, the undersigned Selling Securityholder intends to distribute the Transfer Restricted Securities listed
above in Item (3) only as follows (if at all): Such Transfer Restricted Securities may be sold from time to time directly by the undersigned Selling Securityholder or, alternatively, through underwriters, broker-dealers or agents. Such Transfer
Restricted Securities may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices. Such sales may be effected in transactions
(which may involve crosses or block transactions) (i) on any national securities exchange or quotation service on which the Registered Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market, (iii) in transactions
otherwise than on such exchanges or services or in the over-the-counter market, or (iv) through the writing of options. In connection with sales of the Transfer Restricted Securities or otherwise, the Selling Securityholder may enter into hedging
transactions with broker-dealers, which may in turn engage in short sales of the Transfer Restricted Securities in the course of hedging the positions they assume. The Selling Securityholder may also sell Transfer Restricted Securities short and
deliver Transfer Restricted Securities to close out such short positions, or loan or pledge Transfer Restricted Securities to broker-dealers that in turn may sell such securities. 

State any exceptions here: 
 By
signing below, the Selling Securityholder acknowledges that it understands its obligation to comply, and agrees that it will comply, with the provisions of the Exchange Act and the rules and regulations thereunder, particularly Regulation M.

 In the event that the Selling Securityholder transfers all or any portion of the Transfer Restricted Securities listed in Item (3) above
after the date on which such information is provided to the Company, the Selling Securityholder agrees to notify the transferee(s) at the time of the transfer of its rights and obligations under this Notice and Questionnaire and the Exchange and
Registration Rights Agreement. 
 By signing below, the Selling Securityholder consents to the disclosure of the information contained herein in
its answers to Items (1) through (6) above and the inclusion of such information in the Shelf Registration Statement and related Prospectus. The Selling Securityholder understands that such information will be relied upon by the Company in
connection with the preparation of the Shelf Registration Statement and related Prospectus. 
 In accordance with the Selling
Securityholder’s obligation under Section 3(b) of the Exchange and Registration Rights Agreement to provide such information as may be required by law for 

  
 5 

 
inclusion in the Shelf Registration Statement, the Selling Securityholder agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein which may occur
subsequent to the date hereof at any time while the Shelf Registration Statement remains in effect. All notices hereunder and pursuant to the Exchange and Registration Rights Agreement shall be made in writing, by hand-delivery, first-class mail, or
air courier guaranteeing overnight delivery as follows: 
  

	 	(i)	To the Company: 

  

 
  

 
  

 
  

 
  

	 	(ii)	With a copy to: 

  

 
  

 
  

 
  

 
 Once this Notice and Questionnaire is executed
by the Selling Securityholder and received by the Company’s counsel, the terms of this Notice and Questionnaire, and the representations and warranties contained herein, shall be binding on, shall inure to the benefit of and shall be
enforceable by the respective successors, heirs, personal representatives, and assigns of the Company and the Selling Securityholder (with respect to the Transfer Restricted Securities beneficially owned by such Selling Securityholder and listed in
Item (3) above). This Agreement shall be governed in all respects by the laws of the State of New York. 

  
 6 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Notice and Questionnaire to be
executed and delivered either in person or by its duly authorized agent. 
 Dated: ______________________ 

 

	
	
	  
	 Selling Securityholder

(Print/type full legal name of beneficial
 owner
of Transfer Restricted Securities)

  

			
		
	By:	 	 
		 	 Name:

Title:

 PLEASE RETURN
THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR RECEIPT ON OR BEFORE [DEADLINE FOR RESPONSE] TO THE COMPANY’S COUNSEL AT: 
  

 
  

 
  

 
  

 
  

 

  
 7 

 Exhibit B 
 FORM OF NOTICE OF TRANSFER PURSUANT TO REGISTRATION STATEMENT 
 Citibank, N.A. 

[Barrick Gold Corporation][Barrick North America Finance LLC] 
 c/o Citibank, N.A. 
 111 Wall Street, 15th Floor 

New York, New York 10005 
 Attention: 15th Floor
Window 
  

	 	Re:	[Barrick Gold Corporation][Barrick North America Finance LLC] (the “Company”) 

	 	    	Notes due 20— (the “Notes”) 

 Dear Sirs: 
 Please be advised that ____________________ has transferred $_______________
aggregate principal amount of the above-referenced Notes pursuant to an effective Registration Statement on Form F-3/F-9 (File No. 333-_______) filed by the Company. 
 We hereby certify that the prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied and that the above-named beneficial owner of the Notes is named as a
“Selling Holder” in the Prospectus dated [—, 20—] or in supplements thereto, and that the aggregate
principal amount of the Notes transferred are the Notes listed in such Prospectus opposite such owner’s name. 
 Dated: 

 

	
	Very truly yours,
	
	  
	(Name):

  

			
		
	By:	 	 
		 	(Authorized Signature)Amended and Restated Employment Agreement - Christopher D. Pappas

 Exhibit 10.1 
 EXECUTION VERSION 
 AMENDED & RESTATED 

EMPLOYMENT AGREEMENT 
 EMPLOYMENT AGREEMENT (this “Agreement”), dated as of June 17, 2010 (the “Effective Date”), among Bain Capital Everest US Holding, Inc., a Delaware corporation
(the “Company”), Bain Capital Everest Manager Holding SCA, an SCA organized under the laws of the Grand Duchy of Luxembourg (“Parent”) and Christopher D. Pappas (the “Executive”). 

W I T N E S S E T H 

WHEREAS, the Company desires to employ the Executive as the Chief Executive Officer of the Company and to pay all of the
Executive’s compensation other than certain equity awards described in this Agreement; and 
 WHEREAS, Parent
desires the Executive to be its Chief Executive Officer, to grant the Executive certain equity awards described in this Agreement and to guarantee the cash compensation of the Executive payable by the Company hereunder; and 

WHEREAS, the Company, Parent and the Executive desire to enter into this Agreement as to the terms of the Executive’s
employment with the Company. 
 NOW, THEREFORE, in consideration of the foregoing, of the mutual promises contained
herein and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
 1. POSITION AND DUTIES. 
 (a) During the Employment Term (as defined in
Section 2 hereof), the Executive shall serve as the Chief Executive Officer of the Company and Parent. In this capacity, the Executive shall have the duties, authorities and responsibilities commensurate with the duties, authorities and
responsibilities of persons in similar capacities in similarly sized companies, and such other duties, authorities and responsibilities as may reasonably be assigned to the Executive that are not inconsistent with the Executive’s position as
Chief Executive Officer of Parent. The Executive shall serve as a member of the Board of Managers (or similar governing body) of Parent (the “Board”) and of the Board of Directors of the Company. The Executive’s principal place
of employment with the Company shall be in Pittsburgh, Pennsylvania, provided that the Executive understands and agrees that the Executive will be required to travel frequently for business purposes. The Executive shall report directly to the
Board. 
 (b) During the Employment Term, the Executive shall devote all of the Executive’s business time, energy, business
judgment, knowledge and skill and the Executive’s reasonable best efforts to the performance of the Executive’s duties with the Company and Parent, provided that the foregoing shall not prevent the Executive from (i) serving on
the boards of directors of non-profit organizations and, with the prior written approval of the Board, other for profit companies; provided that the Executive shall be permitted to serve on the board of directors of Allegheny Energy, Inc. or
FirstEnergy Corp., (ii) participating in charitable, civic, educational, 

  
 1 

 professional, community or industry affairs, and (iii) managing the Executive’s passive personal
investments so long as such activities in the aggregate do not violate Section 10 hereof, interfere or conflict with the Executive’s duties hereunder or create a business or fiduciary conflict. 

2. EMPLOYMENT TERM. The Company agrees to employ the Executive pursuant to the terms of this Agreement, and the Executive agrees
to be so employed, for a term of three (3) years (the “Initial Term”) commencing upon the Effective Date. On each anniversary of the Effective Date following the Initial Term, the term of this Agreement shall be automatically
extended for successive one-year periods, provided, however, that either party hereto may elect not to extend this Agreement by giving written notice to the other party at least ninety (90) days prior to any such anniversary date.
Notwithstanding the foregoing, the Executive’s employment hereunder may be earlier terminated in accordance with Section 7 hereof, subject to Section 8 hereof. The period of time between the Effective Date and the
termination of the Executive’s employment hereunder shall be referred to herein as the “Employment Term.” 

3. BASE SALARY. The Company agrees to pay the Executive a base salary for calendar year 2010 at an annual rate of not less than
$800,000, payable in accordance with the regular payroll practices of the Company, but not less frequently than monthly. The Executive’s base salary shall be subject to annual review by the Board (or a committee thereof) during the first ninety
(90) days of each calendar year, and the base salary in respect of such calendar year may be increased above, but not decreased below, its level for the preceding calendar year, by the Board. The base salary as determined herein and adjusted
from time to time shall constitute “Base Salary” for purposes of this Agreement. 
 4. ANNUAL BONUS.
During the Employment Term, the Executive shall be eligible for an annual cash performance bonus (an “Annual Bonus”) in respect of each calendar year that ends during the Employment Term, to the extent earned based on performance
against objective performance criteria. The performance criteria for any particular calendar year shall be determined in good faith by the Board, after consultation with the Executive, no later than ninety (90) days after the commencement of
such calendar year. The Executive’s targeted Annual Bonus for a calendar year shall equal 100% of the Executive’s Base Salary for such calendar year (the “Target Bonus”) if target levels of performance for such year are
achieved, with greater or lesser amounts (including zero) paid for performance above and below target (such greater and lesser amounts to be determined by a formula established by the Board for such year when it establishes the targets and
performance criteria for such year); provided that the Executive’s maximum Annual Bonus for any calendar year during the Employment Term shall equal 200% of the Executive’s Base Salary for such calendar year (the “Maximum
Bonus”). The Executive’s Target Bonus and Maximum Bonus shall be subject to annual review by the Board (or a committee thereof) during the first ninety (90) days of each calendar year, and the Target Bonus and Maximum Bonus for
such calendar year may be increased above, but not decreased below, the levels for the preceding calendar year, by the Board. The Executive’s Annual Bonus for a calendar year shall be determined by the Board after the end of the applicable
calendar year based on the level of achievement of the applicable performance criteria, and shall be paid to the Executive in the calendar year following the calendar year to which such Annual Bonus relates at the same time annual bonuses are paid
to other senior executives of the Company, subject to continued employment at the time of payment (except as otherwise provided in Section 8 

  
 2 

 hereof). Notwithstanding the foregoing, with respect to the 2010 calendar year, the Executive shall receive
an Annual Bonus equal to the greater of (a) the Target Bonus, and (b) the Annual Bonus for calendar year 2010 based on actual results for such year, in each case, prorated for the portion of 2010 that the Executive was employed by the
Company (determined by multiplying the Target Bonus or the Annual Bonus, as applicable, by a fraction, the numerator of which is the number of days during the calendar year that the Executive was employed by the Company and the denominator of which
is 365), payable in accordance with this Section 4. 
 5. EQUITY AWARD. Upon the Effective Date, the
Executive shall be granted by Parent an equity award on such terms and conditions as are set forth on Exhibit A attached hereto. 
 6. EMPLOYEE BENEFITS. 
 (a) BENEFIT PLANS. During the Employment
Term, the Executive shall be entitled to participate in any employee benefit plan that the Company, Parent or any of their direct or indirectly controlled subsidiaries (each an “Affiliate”) has adopted or may adopt, maintain or
contribute to and which benefit any of the senior executives of the Company, Parent or any Affiliate, on a basis no less favorable than that applicable to any such senior executives, subject to satisfying the applicable eligibility requirements,
except to the extent such plans are duplicative of the benefits otherwise provided hereunder. The Executive’s participation in any such employee benefit plan shall be subject to the terms of the applicable plan documents and generally
applicable Company policies. Notwithstanding the foregoing, the Company may modify or terminate any employee benefit plan at any time, if and to the extent allowed pursuant to the terms of such plan, provided that any such amendment may have no more
adverse affect on the Executive than on any other participant in such plan. The Company may provide perquisites to the Executive at the discretion of the Board. 
 (b) VACATIONS. During the Employment Term, the Executive shall be entitled to paid vacation in accordance with the Company’s policy on accrual and use applicable to employees as in effect from
time to time based; provided that the Executive’s vacation accrual shall be calculated as if the Executive had thirty (30) years of employment with the Company. 

(c) RETIREMENT BENEFITS. The Company shall provide the Executive with a retirement benefit in accordance with Exhibit B
attached hereto (the “Retirement Benefit”). For purposes of determining the Executive’s retirement benefit, (i) on the Effective Date, the Executive shall be treated as having six (6) Years of Service Credit with the
Company, (ii) if the Executive is employed by the Company on the first (1st) anniversary of the Effective Date, the Executive shall be granted an additional six (6) Years of Service Credit with the Company (for a total of twelve
(12) Years of Service Credit with the Company), (iii) if the Executive is employed by the Company on the second (2nd) anniversary of the Effective Date, the Executive shall be granted an additional six (6) Years of Service Credit
with the Company (for a total of eighteen (18) Years of Service Credit with the Company), (iv) if the Executive is employed by the Company on the third (3rd) anniversary of the Effective Date, the Executive shall be granted an
additional six (6) Years of Service Credit with the Company (for a total of twenty-four (24) Years of Service Credit with the Company), and (v) if the Executive is employed by the Company on the fourth (4th) anniversary of the
Effective Date, the Executive shall be granted an 

  
 3 

 additional six (6) Years of Service Credit with the Company (for a total of thirty (30) Years of
Service Credit with the Company). Upon a Change in Control while the Executive is employed by the Company, the Executive shall be granted Years of Service Credit with the Company sufficient to reach an aggregate of thirty (30) Years of Service
Credit with the Company. For the sake of clarity, in no event shall the Executive receive more than an aggregate of thirty (30) Years of Service Credit with the Company. Notwithstanding any other provision herein to the contrary, in the event
that the Executive’s employment is terminated (A) by the Company for Cause, or (B) by the Executive without Good Reason, in either case, prior to the expiration of the Initial Term, the Executive shall be deemed to have zero
(0) Years of Service Credit with the Company for purposes of this Section 6(c) and Exhibit B attached hereto. 
 (d) BUSINESS EXPENSES. Upon presentation of reasonable substantiation and documentation as the Company may specify from time to time, the Executive shall be reimbursed in accordance with the
Company’s expense reimbursement policies as in effect from time to time, for all reasonable out-of-pocket business expenses incurred and paid by the Executive during the Employment Term and in connection with the performance of the
Executive’s duties hereunder. 
 (e) LEGAL FEES. Upon presentation of an invoice therefor, the Company shall pay or
reimburse the Executive’s reasonable counsel fees incurred in connection with the negotiation and documentation of this Agreement and the other documents ancillary thereto. 

7. TERMINATION. The Executive’s employment and the Employment Term shall terminate on the first of the
following to occur: 
 (a) DISABILITY. Upon ten (10) days’ prior written notice by the Company to the Executive
of termination due to Disability. For purposes of this Agreement, “Disability” shall be defined as the inability of the Executive to have performed the Executive’s material duties hereunder due to a physical or mental injury,
infirmity or incapacity, which inability shall continue for one hundred and twenty (120) consecutive days or for one hundred eighty (180) days (including weekends and holidays) in any 365-day period as determined by the Board in its
reasonable discretion. The Executive shall cooperate in all respects with the Company if a question arises as to whether the Executive has become disabled (including, without limitation, submitting to reasonable examinations by one or more medical
doctors and other health care specialists selected by the Company and authorizing such medical doctors and other health care specialists to discuss the Executive’s condition with the Company). 

(b) DEATH. Automatically upon the date of death of the Executive. 

(c) CAUSE. Immediately upon written notice by the Company to the Executive of a termination for Cause. “Cause”
shall mean the Executive’s (i) continued failure to follow the lawful directives of the Board after written notice from the Board and a period of no less than thirty (30) days to cure such failure; (ii) willful misconduct or
gross negligence in the performance of the Executive’s duties; (iii) conviction of, or pleading of guilty or nolo contendere to, a felony; (iv) material violation of a material Company policy that is not cured within fifteen
(15) days of written notice from the Board; (v) performance of any material act of theft, embezzlement, fraud or misappropriation of or in respect of the Company’s property; (vi)

  
 4 

 continued failure to cooperate in any audit or investigation of financial or business practices of the
Company after written request for cooperation from the Board and a period of no less than ten (10) days to cure such failure; or (vii) breach of any of the restrictive covenants set forth in Section 10 hereof or in any other
written agreement between the Executive and the Company and/or its affiliates that causes material and demonstrable harm to the Company and that is not cured within fifteen (15) days of written notice from the Board (a “Material
Covenant Violation”). 
 For purposes of this Section 7(c), no act, or failure to act, on the part of the
Executive shall be considered “willful” unless it is done, or omitted to be done, by the Executive in bad faith or without reasonable belief that the Executive’s action or omission was in the best interests of the Company. Any act, or
failure to act, based upon (A) authority given pursuant to a resolution duly adopted by the Board or the board of directors of the Company or (B) the advice of counsel for the Company or Parent shall be conclusively presumed to be done, or
omitted to be done, by the Executive in good faith and in the best interests of the Company. The cessation of employment of the Executive shall not be deemed to be for Cause unless and until there shall have been delivered to the Executive a copy of
a resolution duly adopted by the affirmative vote of not less than a majority of the entire membership of the Board (excluding the Executive, if the Executive is a member of the Board) at a meeting of the Board called and held for such purpose
(after reasonable notice is provided to the Executive and the Executive is given an opportunity, together with counsel for the Executive, to be heard before the Board), finding that, in the good faith opinion of the Board, the Executive is guilty of
the conduct described in one or more of clauses (i) through (vii) of the preceding paragraph, and specifying the particulars thereof in detail. 
 (d) WITHOUT CAUSE. Immediately upon written notice by the Company to the Executive of an involuntary termination without Cause (other than for death or Disability). 

(e) GOOD REASON. Upon written notice by the Executive to the Company of a termination for Good Reason. “Good
Reason” shall mean the occurrence of any of the following events, without the express written consent of the Executive, unless such events are fully corrected in all material respects by the Company or Parent (as applicable) within thirty
(30) days following written notification by the Executive to the Company of the occurrence of one of the reasons set forth below: (i) the material diminution in the Executive’s position, duties or authorities or assignment of duties
materially inconsistent with the Executive’s position with Parent, including but not limited to the Executive ceasing to be the sole Chief Executive Officer of Parent, and a member of the Board; (ii) the Executive’s relocation of the
Executive’s primary work location by more than thirty-five (35) miles from its then current location; (iii) a reduction in Base Salary or Target Bonus; (iv) the Company giving notice of non-extension of this Agreement; or
(v) a material breach of this Agreement by the Company or Parent (excluding any material breach relating to any diminution in the Executive’s position, duties or authorities or assignment of duties inconsistent with the Executive’s
position with the Company). The Executive shall provide the Company with a written notice detailing the specific circumstances alleged to constitute Good Reason within ninety (90) days after the Executive first gains actual knowledge of the
occurrence of such circumstances, and actually terminate employment within thirty (30) days following the expiration of the Company’s thirty (30)-day correction period 

  
 5 

 
described above. Otherwise, any claim of such circumstances as “Good Reason” shall be deemed irrevocably waived by the Executive. 

(f) WITHOUT GOOD REASON. Upon ninety (90) days’ prior written notice by the Executive to the Company of the
Executive’s voluntary termination of employment without Good Reason (which the Company may, in its sole discretion, make effective earlier than any notice date). 
 (g) EXPIRATION OF EMPLOYMENT TERM; NON-EXTENSION OF AGREEMENT. Upon the expiration of the Employment Term due to a non-extension of the Agreement by the Company or the Executive pursuant to the
provisions of Section 2 hereof (in the case of a non-extension by the Company, without the Executive having terminated for Good Reason in respect of such non-extension). 

8. CONSEQUENCES OF TERMINATION. 
 (a) DEATH. In the event that the Executive’s employment and the Employment Term ends on account of the Executive’s death, the Executive or the Executive’s estate, as the case may be,
shall be entitled to the following (with the amounts due under Sections 8(a)(i) through 8(a)(v) hereof to be paid, unless otherwise provided below, within sixty (60) days following termination of employment, or such earlier date
as may be required by applicable law): 
 (i) any unpaid Base Salary through the date of termination; 

(ii) any Annual Bonus earned but unpaid with respect to the calendar year ending on or preceding the date of termination; 

(iii) an amount equal to the pro-rata portion of the Executive’s Target Bonus for the calendar year of
termination (determined by multiplying the Target Bonus for the year of termination by a fraction, the numerator of which is the number of days during the calendar year of termination that the Executive is employed by the Company and the denominator
of which is 365); provided that to the extent that the payment of such amount constitutes “nonqualified deferred compensation” for purposes of “Code Section 409A” (as defined in Section 24 hereof), such
payment shall be made on the sixtieth (60th) day
following such termination; 
 (iv) reimbursement for any unreimbursed business expenses incurred through the date of
termination; 
 (v) payment in respect of any accrued but unused vacation time in accordance with Company policy; 

(vi) subject to Section 6(c), the Retirement Benefit; and 
 (vii) all other payments, benefits or fringe benefits to which the Executive shall be entitled under the terms of any applicable compensation arrangement or benefit, equity or fringe benefit plan or
program or grant or this Agreement (collectively, Sections 8(a)(i) through 8(a)(vii) hereof shall be hereafter referred to as the “Accrued Benefits”). 

  
 6 

 (b) DISABILITY. In the event that the Executive’s employment and/or Employment
Term ends on account of the Executive’s Disability, the Company shall pay or provide the Executive with the Accrued Benefits. 
 (c) TERMINATION FOR CAUSE OR WITHOUT GOOD REASON OR AS A RESULT OF EXECUTIVE NON-EXTENSION OF THIS AGREEMENT. If the Executive’s employment is terminated (x) by the Company for Cause,
(y) by the Executive without Good Reason, or (z) as a result of the Executive’s non-extension of the Employment Term as provided in Section 2 hereof, the Company shall pay to the Executive the Accrued Benefits (other than
the benefits described in Sections 8(a)(ii) and 8(a)(iii) hereof). 
 (d) TERMINATION WITHOUT CAUSE OR FOR GOOD
REASON. If the Executive’s employment by the Company is terminated (x) by the Company other than for Cause pursuant to Section 7(d) hereof, or (y) by the Executive for Good Reason, the Company shall pay or provide the
Executive with the following, subject to the provisions of Section 24 hereof: 
 (i) the Accrued Benefits;

 (ii) subject to the Executive’s not engaging in a Material Covenant Violation or a material breach of
Section 11 hereof that is not cured within fifteen (15) days of written notice from the Board (a “Material Cooperation Violation”), the Executive shall be entitled to one (but not both) of the following payments, as
applicable: 
 (A) if the Executive’s employment is terminated pursuant to this
Section 8(d) prior to the third (3rd) anniversary of the Effective Date, an amount equal to three (3) multiplied by the sum of the Executive’s Base Salary and Target Bonus for the year of termination (the “Clause A
Severance Amount”), paid in equal monthly installments for a period of twenty-four (24) months following such termination; provided that to the extent that the payment of any amount constitutes “nonqualified deferred
compensation” for purposes of Code Section 409A, any such payment scheduled to occur during the first sixty (60) days following the termination of employment shall not be paid until the sixtieth (60th) day following such termination and shall include payment of
any amount that was otherwise scheduled to be paid prior thereto; or 
 (B) if the Executive’s
employment is terminated pursuant to this Section 8(d) on or after the third (3rd) anniversary of the Effective Date, an amount equal to two (2) multiplied by the sum the Executive’s Base Salary and Target Bonus for the
year of termination (the “Clause B Severance Amount”), paid in equal monthly installments for a period of twenty-four (24) months following such termination; provided that to the extent that the payment of any amount
constitutes “nonqualified deferred compensation” for purposes of Code Section 409A, any such payment scheduled to occur during the first sixty (60) days following the termination of employment shall not be paid until the sixtieth
(60th) day following such termination and shall
include payment of any amount that was otherwise scheduled to be paid prior thereto; and 
 (iii) subject to (A) the
Executive’s timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), 

  
 7 

 
(B) the Executive’s continued copayment of premiums at the same level and cost to the Executive as if the Executive were an employee of the Company (excluding, for purposes of calculating
cost, an employee’s ability to pay premiums with pre-tax dollars), and (C) the Executive’s not engaging in a Material Covenant Violation or a Material Cooperation Violation, continued participation in the Company’s group health
plan (to the extent permitted under applicable law) which covers the Executive (and the Executive’s eligible dependents) for a period of thirty-six (36) months (if the Clause A Severance Amount is payable) or twenty-four (24) months
(if the Clause B Severance Amount is payable) following the Executive’s date of termination, at the Company’s expense, provided that if the Company’s group health plan is self-insured, the Company will report to the appropriate
tax authorities taxable income to the Executive equal to the portion of the deemed cost of such participation (based on applicable COBRA rates) not paid by the Executive; and provided, further, that in the event that the Executive
obtains other employment that offers group health benefits, such continuation of coverage by the Company under this Section 8(d)(iii) shall immediately cease. 
 Payments and benefits provided in this Section 8(d) shall be in lieu of any termination or severance payments or benefits for which the Executive may be eligible under any of the plans,
policies or programs of the Company or under the Worker Adjustment Retraining Notification Act of 1988 or any similar state statute or regulation. 
 (e) CHANGE IN CONTROL. 
 (i) This
Section 8(e) shall apply if the Executive’s employment by the Company is terminated (x) by the Company other than for Cause pursuant to Section 7(d) hereof, or (y) by the Executive for Good Reason, in either
case, during the two (2)-year period commencing upon a Change in Control. Subject to the Executive’s not engaging in a Material Covenant Violation or a Material Cooperation Violation, upon a termination described in the preceding sentence, the
Executive shall receive the benefits set forth in Section 8(d) hereof, except that in lieu of receiving the Clause A Severance Amount or the Clause B Severance Amount, as applicable, in installments as contemplated under Sections
8(d)(ii)(A) and 8(d)(ii)(B) hereof, the Executive shall receive a lump sum payment equal to the Clause A Severance Amount or the Clause B Severance Amount, as applicable, on the date of such termination; provided that to the
extent that the payment of the applicable amount constitutes “nonqualified deferred compensation” for purposes of Code Section 409A, such payment shall be made on the sixtieth
(60th) day following such termination. 

(ii) For purposes of this Agreement, the term “Change in Control” shall mean the consummation of the first transaction
following the Effective Date, whether in a single transaction or in a series of related transactions, in which any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as
amended) (a “Group”), other than Bain Capital Partners, any private equity fund managed by it, or any Group which includes Bain Capital Partners or any private equity fund managed by it, (A) acquires (whether by merger,
consolidation, or transfer or issuance of equity interests or otherwise) equity interests of Parent (or any surviving or resulting entity) representing more than fifty percent (50%) of the outstanding voting securities or economic value of
Parent (or any surviving or resulting entity), or (B) acquires assets constituting all or substantially all (more 

  
 8 

 
than eighty percent (80%)) of the assets of Parent and its subsidiaries (as determined on a consolidated basis). 
 (f) CODE SECTION 280G. To the extent that any amount or benefit that may be paid or otherwise provided to or in respect of the Executive by the Company or any affiliated company, whether pursuant
to this Agreement or otherwise, exceeds the limitations of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”) such that an excise tax would be imposed under Section 4999 of the Code, the provisions
of Exhibit C attached hereto shall be applicable. 
 (g) OTHER OBLIGATIONS. Upon any termination of the
Executive’s employment with the Company, the Executive shall promptly resign from the Board and any other position as an officer, director or fiduciary of the Company, Parent and any Affiliate. 

9. RELEASE; NO MITIGATION; NO SET-OFF. Any and all amounts payable and benefits or additional rights provided pursuant to this
Agreement beyond the Accrued Benefits (other than the amount described in Section 8(a)(iii) hereof) shall only be payable if the Executive delivers to the Company and does not revoke a general release of claims in favor of the Company in
substantially the form of Exhibit D attached hereto. Such release shall be executed and delivered (and no longer subject to revocation, if applicable) within sixty (60) days following termination. In no event shall the Executive be
obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement, nor shall the amount of any payment hereunder be reduced by any compensation
earned by the Executive as a result of employment by a subsequent employer (except as provided in Section 8(d)(iii) hereof). The Company’s obligations to pay the Executive amounts hereunder shall not be subject to set-off,
counterclaim or recoupment of amounts owed by the Executive to the Company or any of its affiliates. 
 10. RESTRICTIVE
COVENANTS. 
 (a) CONFIDENTIALITY. During the course of the Executive’s employment with the Company and its
Affiliates, the Executive will learn confidential information regarding Parent and its Affiliates (the “Parent Group”). The Executive agrees that the Executive shall not, directly or indirectly, use, make available, sell, disclose
or otherwise communicate to any person, other than in the course of the Executive’s assigned duties and for the benefit of the Parent Group, either during the period of the Executive’s employment or at any time thereafter, any business and
technical information or trade secrets, nonpublic, proprietary or confidential information, knowledge or data relating to the Parent Group, or received from third parties subject to a duty on the Parent Group’s part to maintain the
confidentiality of such information and to use it only for certain limited purposes, in each case which shall have been obtained by the Executive during the Executive’s employment by the Parent Group. The foregoing shall not apply to
information that (i) was known to the public prior to its disclosure to the Executive; (ii) becomes generally known to the public subsequent to disclosure to the Executive through no wrongful act of the Executive or any representative of
the Executive; or (iii) the Executive is required to disclose by applicable law, regulation or legal process (provided that the Executive provides the Company with prior notice of the contemplated disclosure and cooperates with the
Company at its expense in seeking a protective order or other appropriate protection of such 

  
 9 

 
information). The terms and conditions of this Agreement shall remain strictly confidential, and the Executive hereby agrees not to disclose the terms and conditions hereof to any person or
entity, other than immediate family members, legal advisors or personal tax or financial advisors, or prospective future employers solely for the purpose of disclosing the limitations on the Executive’s conduct imposed by the provisions of this
Section 10 who, in each case, shall be instructed by the Executive to keep such information confidential. 
 (b)
NONCOMPETITION. The Executive acknowledges that the Executive performs services of a unique nature for the Parent Group that are irreplaceable, and that the Executive’s performance of such services to a competing business will result in
irreparable harm to the Parent Group. Accordingly, during the Executive’s employment hereunder and for a period of two (2) years thereafter, the Executive agrees that the Executive will not, directly or indirectly, own, manage, operate,
control, be employed by (whether as an employee, consultant, independent contractor or otherwise, and whether or not for compensation) or render services to any person, firm, corporation or other entity, in whatever form, engaged in competition with
any material business of the Parent or any Affiliate or in any other material business in which the Parent or any Affiliate has taken material steps and has material plans, on or prior to the date or termination, to be engaged in on or after such
date, in any locale of any country in which the Company or such Affiliate conducts business. Notwithstanding the foregoing, nothing herein shall prohibit the Executive from being a passive owner of not more than one percent (1%) of the equity
securities of a publicly traded corporation engaged in a business that is in competition with Parent or any of its Affiliates, so long as the Executive has no active participation in the business of such corporation. 

(c) NONSOLICITATION; NONINTERFERENCE. During the Executive’s employment with the Company and for a period of two
(2) years thereafter, the Executive agrees that the Executive shall not, except in the furtherance of the Executive’s duties hereunder, directly or indirectly, individually or on behalf of any other person, firm, corporation or other
entity, (i) solicit, aid or induce any customer of Parent or an Affiliate to purchase goods or services then sold by Parent or any Affiliate from another person, firm, corporation or other entity or assist or aid any other persons or entity in
identifying or soliciting any such customer, (ii) solicit, aid or induce any employee, representative or agent of Parent or any Affiliate to leave such employment or retention or, in the case of employees, to accept employment with or render
services to or with any other person, firm, corporation or other entity unaffiliated with Parent or any Affiliate, or hire or retain any such employee, or take any action to materially assist or aid any other person, firm, corporation or other
entity in identifying, hiring or soliciting any such employee, or (iii) interfere, or aid or induce any other person or entity in interfering, with the relationship between Parent or any Affiliate and any of their respective vendors, joint
venturers or licensors. An employee, representative or agent shall be deemed covered by this Section 10(c) while so employed or retained and for a period of six (6) months thereafter. Notwithstanding the foregoing, the provisions of
this Section 10(c) shall not be violated by general advertising or solicitation not specifically targeted at Parent or Affiliate-related individuals or entities. 
 (d) INVENTIONS. (i) The Executive acknowledges and agrees that all ideas, methods, inventions, discoveries, improvements, work products, developments or works of authorship
(“Inventions”), whether patentable or unpatentable, (A) that relate to the Executive’s 

  
 10 

 work with the Parent Group, made or conceived by the Executive, solely or jointly with others, during the
Employment Term, or (B) suggested by any work that the Executive performs in connection with the Parent Group, either while performing the Executive’s duties with the Parent Group or on the Executive’s own time, shall belong
exclusively to the Company (or its designee), whether or not patent applications are filed thereon. The Executive will keep full and complete written records (the “Records”), in the manner prescribed by the Company, of all
Inventions, and will promptly disclose all Inventions completely and in writing to the Company. The Records shall be the sole and exclusive property of the member of the Parent Group designated by Parent, and the Executive will surrender them upon
the termination of the Employment Term, or upon the Company’s request. The Executive will assign to the member of the Parent Group designated by Parent the Inventions and all patents that may issue thereon in any and all countries, whether
during or subsequent to the Employment Term, together with the right to file, in the Executive’s name or in the name of the member of the Parent Group designated by Parent, applications for patents and equivalent rights (the
“Applications”). The Executive will, at any time during and subsequent to the Employment Term, make such applications, sign such papers, take all rightful oaths, and perform all acts as may be requested from time to time by the
Company with respect to the Inventions. The Executive will also execute assignments to the member of the Parent Group designated by Parent of the Applications, and give the member of the Parent Group designated by Parent and its attorneys all
reasonable assistance (including the giving of testimony) to obtain the Inventions for the Parent Group’s benefit, all without additional compensation to the Executive from the Parent Group. 

(ii) In addition, the Inventions will be deemed Work for Hire, as such term is defined under the copyright laws of the United States, on
behalf of the Parent Group and the Executive agrees that the member of the Parent Group designated by Parent will be the sole owner of the Inventions, and all underlying rights therein, in all media now known or hereinafter devised, throughout the
universe and in perpetuity without any further obligations to the Executive. If the Inventions, or any portion thereof, are deemed not to be Work for Hire, the Executive hereby irrevocably conveys, transfers and assigns to the member of the Parent
Group designated by Parent, all rights, in all media now known or hereinafter devised, throughout the universe and in perpetuity, in and to the Inventions, including, without limitation, all of the Executive’s right, title and interest in the
copyrights (and all renewals, revivals and extensions thereof) to the Inventions, including, without limitation, all rights of any kind or any nature now or hereafter recognized, including, without limitation, the unrestricted right to make
modifications, adaptations and revisions to the Inventions, to exploit and allow others to exploit the Inventions and all rights to sue at law or in equity for any infringement, or other unauthorized use or conduct in derogation of the Inventions,
known or unknown, prior to the date hereof, including, without limitation, the right to receive all proceeds and damages therefrom. In addition, the Executive hereby waives any so-called “moral rights” with respect to the Inventions. To
the extent that the Executive has any rights in the results and proceeds of the Inventions that cannot be assigned in the manner described herein, the Executive agrees to unconditionally waive the enforcement of such rights. The Executive hereby
waives any and all currently existing and future monetary rights in and to the Inventions and all patents that may issue thereon, including, without limitation, any rights that would otherwise accrue to the Executive’s benefit by virtue of the
Executive being an employee of or other service provider to the Parent Group. 

  
 11 

 (e) RETURN OF COMPANY PROPERTY. On the date of the Executive’s termination of
employment with the Company for any reason (or at any time prior thereto at the Company’s request), the Executive shall return all property belonging to the Company or its Affiliates (including, but not limited to, any Company-provided laptops,
computers, cell phones, wireless electronic mail devices or other equipment, or documents and property belonging to the Company). The Executive may retain the Executive’s rolodex and similar address books provided that such items only include
contact information. 
 (f) REASONABLENESS OF COVENANTS. In signing this Agreement, the Executive gives Parent and the
Company assurance that the Executive has carefully read and considered all of the terms and conditions of this Agreement, including the restraints imposed under this Section 10. The Executive agrees that these restraints are necessary
for the reasonable and proper protection of the Company and its Affiliates and their trade secrets and confidential information and that each and every one of the restraints is reasonable in respect to subject matter, length of time and geographic
area, and that these restraints, individually or in the aggregate, will not prevent the Executive from obtaining other suitable employment during the period in which the Executive is bound by the restraints. The Executive acknowledges that each of
these covenants has a unique, very substantial and immeasurable value to the Company and its Affiliates and that the Executive has sufficient assets and skills to provide a livelihood while such covenants remain in force. The Executive further
covenants that the Executive will not challenge the reasonableness or enforceability of any of the covenants set forth in this Section 10, other than in response to an attempt by the Company or an Affiliate to enforce such covenants
against the Executive. It is also agreed that the Affiliates will have the right to enforce all of the Executive’s obligations to such Affiliates under this Agreement, including without limitation pursuant to this Section 10.

 (g) REFORMATION. If it is determined by a court of competent jurisdiction in any state that any restriction in this
Section 10 is excessive in duration or scope or is unreasonable or unenforceable under applicable law, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the
maximum extent permitted by the laws of that state. 
 (h) TOLLING. In the event of any violation of the provisions of
this Section 10, the Executive acknowledges and agrees that the post-termination restrictions contained in this Section 10 shall be extended by a period of time equal to the period of such violation, it being the intention of
the parties hereto that the running of the applicable post-termination restriction period shall be tolled during any period of such violation. 
 (i) SURVIVAL OF PROVISIONS. The obligations contained in Sections 10 and 11 hereof shall survive the termination or expiration of the Employment Term and the Executive’s
employment with the Company and shall be fully enforceable thereafter. 
 11. COOPERATION. Upon the receipt of reasonable
notice from the Company (including through outside counsel), the Executive agrees that while employed by the Company and thereafter (to the extent it does not materially interfere with the Executive’s employment or other business activities
after employment by the Company), the Executive will respond and provide information with regard to matters in which the Executive has knowledge as a result of 

  
 12 

 
the Executive’s employment with the Company, and will provide reasonable assistance to the Company, the Affiliates and their respective representatives in defense of all claims that may be
made against the Company or the Affiliates, and will assist the Company and the Affiliates in the prosecution of all claims that may be made by the Company or the Affiliates, to the extent that such claims may relate to the period of the
Executive’s employment with the Company. The Executive also agrees to promptly inform the Company (to the extent that the Executive is legally permitted to do so) if the Executive is asked to assist in any investigation of the Company or the
Affiliates (or their actions), regardless of whether a lawsuit or other proceeding has then been filed against the Company or Affiliates with respect to such investigation, and shall not do so unless legally required. Upon presentation of
appropriate documentation, the Company shall pay or reimburse the Executive for all reasonable out-of-pocket travel, duplicating, telephonic, counsel and other expenses incurred by the Executive in complying with this Section 11.

 12. EQUITABLE RELIEF AND OTHER REMEDIES. The Executive acknowledges and agrees that the remedies at law for a breach
or threatened breach of any of the provisions of Section 10 hereof or Section 11 hereof would be inadequate and, in recognition of this fact, the Executive agrees that, in the event of such a breach or threatened breach, in
addition to any remedies at law, Parent and/or the Company shall be entitled to obtain equitable relief in the form of specific performance, a temporary restraining order, a temporary or permanent injunction or any other equitable remedy which may
then be available. In the event of a Material Covenant Violation or a Material Cooperation Violation by the Executive, any severance being paid to the Executive pursuant to this Agreement or otherwise shall immediately cease. 

13. NO ASSIGNMENTS. This Agreement is personal to each of the parties hereto. Except as provided in this Section 13
hereof, no party may assign or delegate any rights or obligations hereunder without first obtaining the written consent of the other party hereto. Parent shall assign this Agreement to any successor to all or substantially all of the business and/or
assets of Parent, provided that Parent shall require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had
taken place. As used in this Agreement, “Parent” shall mean Parent and any successor to all or substantially all of its business and/or assets, which assumes and agrees to perform the duties and obligations of Parent under this
Agreement by operation of law or otherwise. In the event of a sale of the Company (or all or substantially all of its business) to an independent third party in connection with a transaction that does not constitute a Change in Control, the Company
and the Executive shall assign the Company’s rights and obligations hereunder to Parent or to a mutually agreed upon direct or indirect subsidiary of Parent, and the Company shall be released from its obligations hereunder. 

14. NOTICES. For purposes of this Agreement, notices and all other communications provided for in this Agreement shall be in
writing and shall be deemed to have been duly given (a) on the date of delivery, if delivered by hand, (b) on the date of transmission, if delivered by confirmed facsimile or electronic mail, (c) on the first business day following
the date of deposit, if delivered by guaranteed overnight delivery service, or (d) on the fourth business day following the date delivered or mailed by United States registered or certified mail, return receipt requested, postage prepaid,
addressed as follows: 
 If to the Executive: 

  
 13 

 615 East Drive 
 Sewickley, Pennsylvania 15143 
 If to the Company: 

STY Acquisition Corp. 
 c/o Bain Capital Partners, LLC 
 590 Madison Avenue, 42nd Floor 

New York, NY 10022 
 Facsimile: (212) 421-2225 
 Attention: Stephen M. Zide 

or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address
shall be effective only upon receipt. 
 15. SECTION HEADINGS; INCONSISTENCY. The section headings used in this Agreement
are included solely for convenience and shall not affect, or be used in connection with, the interpretation of this Agreement. In the event of any inconsistency between the terms of this Agreement (including the Exhibits hereto) and any form, award,
plan or policy of the Company, the terms of this Agreement shall govern and control. 
 16. SEVERABILITY. The provisions
of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. 

17. COUNTERPARTS. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all
of which together will constitute one and the same instrument. 
 18. INDEMNIFICATION. The Company hereby agrees to
indemnify the Executive and hold the Executive harmless to the fullest extent allowable under applicable law against and in respect of any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses (including attorney’s
fees, and the advancement of such fees subject to any legally required repayment undertaking), losses, and damages resulting from the Executive’s performance of the Executive’s duties and obligations with the Company. This obligation shall
survive the termination of the Executive’s employment with the Company. 
 19. LIABILITY INSURANCE. The Company
shall cover the Executive under directors’ and officers’ liability insurance both during and, while potential liability exists, after the Employment Term in the same amount and to the same extent as the Company covers its other officers
and directors. 
 20. GOVERNING LAW. This Agreement, the rights and obligations of the parties hereto, and any claims or
disputes relating thereto, shall be governed by and construed in accordance with the laws of the State of Delaware (but not including any choice of law rule thereof that would cause the laws of another jurisdiction to apply). 

  
 14 

 21. DISPUTE RESOLUTION. Each of the parties agrees that any dispute between the
parties shall be resolved only in the courts of the State of Delaware or the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts. In that context, and without limiting the
generality of the foregoing, each of the parties hereto irrevocably and unconditionally (a) submits in any proceeding relating to this Agreement or the Executive’s employment by the Company or any Affiliate, or for the recognition and
enforcement of any judgment in respect thereof (a “Proceeding”), to the exclusive jurisdiction of the courts of the State of Delaware, the court of the United States of America for the District of Delaware, and appellate courts
having jurisdiction of appeals from any of the foregoing, and agrees that all claims in respect of any such Proceeding shall be heard and determined in such Delaware State court or, to the extent permitted by law, in such federal court,
(b) consents that any such Proceeding may and shall be brought in such courts and waives any objection that the Executive or the Company may now or thereafter have to the venue or jurisdiction of any such Proceeding in any such court or that
such Proceeding was brought in an inconvenient court and agrees not to plead or claim the same, (c) WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT
OR THE EXECUTIVE’S EMPLOYMENT BY THE COMPANY OR ANY AFFILIATE OF THE COMPANY, OR THE EXECUTIVE’S OR THE COMPANY’S PERFORMANCE UNDER, OR THE ENFORCEMENT OF, THIS AGREEMENT, (d) agrees that service of process in any such Proceeding
may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such party at the Executive’s or the Company’s address as provided in Section 14
hereof, and (e) agrees that nothing in this Agreement shall affect the right to effect service of process in any other manner permitted by the laws of the State of Delaware. Each party shall be responsible for its own legal fess incurred in
connection with any dispute hereunder. 
 22. MISCELLANEOUS. No provision of this Agreement may be modified, waived or
discharged unless such waiver, modification or discharge is agreed to in writing and signed by the Executive and such officer or director as may be designated by the Board. No waiver by either party hereto at any time of any breach by the other
party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. This
Agreement together with all exhibits hereto sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes any and all prior agreements or understandings between the Executive and the Company
with respect to the subject matter hereof, whether written or oral and, on the Effective Date, supersedes and terminates the Employment Agreement dated as of March 25, 2010 among STY Acquisition Corp., Parent and Executive. No agreements or
representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not expressly set forth in this Agreement. 

23. REPRESENTATIONS; ACTIONS BY PRIOR EMPLOYERS. The Executive represents and warrants to the Company that (a) the Executive
has used the Executive’s best efforts to provide the Company with (i) each agreement with a predecessor employer which may have any bearing on the Executive’s legal right to enter into this Agreement and to perform all of the
obligations on the Executive’s part to be performed 

  
 15 

 
hereunder in accordance with its terms, or (ii) a summary of the applicable provisions of each such agreement which the Executive may not provide to the Company due to an existing
confidentiality obligation, and (b) other than the agreements referenced in the preceding clause (a), the Executive is not a party to any agreement or understanding, whether written or oral, and is not subject to any restriction (including,
without limitation, any non-competition restriction from a prior employer), which, in either case, could prevent the Executive from entering into this Agreement or performing all of the Executive’s duties and obligations hereunder. The
Executive understands that the foregoing representations are a material inducement to Parent and the Company entering into this Agreement, and to the extent that either of such representations is untrue in any material respect at any time or for any
reason, this Agreement shall be voidable by Parent and the Company such that the parties hereunder shall be relieved of all of their respective duties and obligations hereunder; provided that any termination of the Executive’s employment
resulting from the Company exercising its rights pursuant to this sentence shall be treated as a termination of employment by the Executive without Good Reason. If any prior employer of the Executive, or any affiliate of any such prior employer,
challenges the Executive’s right to enter into this Agreement and to perform all of the Executive’s obligations hereunder (whether by action against the Executive, the Company, Parent and/or an Affiliate), the Company, Parent (on behalf of
itself and all Affiliates) and the Executive each agree to use their reasonable best efforts to defend against such challenge, and the Company further agrees to pay as incurred (within 10 days following the Company’s receipt of an invoice from
the Executive), at any time from the Effective Date through the Executive’s remaining lifetime (or, if longer, through the 20th anniversary of the Effective Date), all legal fees and expenses that the Executive may reasonably incur as a result of
his personal defense of such challenge. 
 24. TAX MATTERS. 

(a) WITHHOLDING. The Company may withhold from any and all amounts payable under this Agreement or otherwise such federal, state
and local taxes as may be required to be withheld pursuant to any applicable law or regulation. 
 (b) SECTION 409A
COMPLIANCE. 
 (i) The intent of the parties is that payments and benefits under this Agreement comply with
Section 409A of the Code and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance
therewith. To the extent that any provision hereof is modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and
economic benefit to the Executive and the Company of the applicable provision without violating the provisions of Code Section 409A. Any such modification shall require the written consent of the Executive. In no event whatsoever shall the
Company be liable for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A or damages for failing to comply with Code Section 409A; provided that the Company makes any modification
reasonably requested by the Executive in accordance with the second sentence of this Section 24(b)(i). 

  
 16 

 (ii) A termination of employment shall not be deemed to have occurred for purposes of any
provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code Section 409A and,
for purposes of any such provision of this Agreement, references to a “termination,” “termination of employment” or like terms shall mean “separation from service.” If the Executive is deemed on the date of termination
to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered “nonqualified deferred compensation” under
Code Section 409A payable on account of a “separation from service,” such payment or benefit shall be made or provided at the date which is the earlier of (A) the expiration of the six (6)-month period measured from the date of
such “separation from service” of the Executive, and (B) the date of the Executive’s death, to the extent required under Code Section 409A. Upon the expiration of the foregoing delay period, all payments and benefits delayed
pursuant to this Section 24(b)(ii) (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump sum and all remaining payments and
benefits due under this Agreement shall be paid or provided in accordance with the normal payment dates specified for them herein. 
 (iii) To the extent that reimbursements or other in-kind benefits under this Agreement constitute “nonqualified deferred compensation” for purposes of Code Section 409A, (A) all
expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by the Executive, (B) any right to reimbursement or in-kind benefits shall
not be subject to liquidation or exchange for another benefit, and (C) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement,
or in-kind benefits to be provided, in any other taxable year. 
 (iv) For purposes of Code Section 409A, the
Executive’s right to receive installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment period with reference to
a number of days, the actual date of payment within the specified period shall be within the sole discretion of the Company. 

25. FURTHER ASSURANCES; PARENT GUARANTEE. The Company and the Executive shall cooperate with each other prior to the Closing and
do, or procure the doing of, all acts and things, and execute, or procure the execution of, all documents, as may reasonably be required to give full effect to this Agreement (including, without limitation, the Company taking such actions as are
necessary to form Parent under applicable law and cause Parent to execute this Agreement prior to the Closing). Parent hereby guarantees the performance of the obligations of the Company to pay all cash amounts due to the Executive pursuant to this
Agreement. In the event that the Company is unable or unwilling to pay any such amounts when due, upon notice of such non-payment received by Parent from the Executive, Parent shall immediately pay such amounts, or take any and all actions necessary
to cause one or more Affiliates to pay such amounts, on behalf of the Company. 

  
 17 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 18 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date
first written above. 
  

					
	BAIN CAPITAL EVEREST US HOLDING, INC.
		
	By:	 	 /s/ Stephen. M. Zide

		
	Name:	 	 Stephen. M. Zide

		
	Title:	 	 President

	
	BAIN CAPITAL EVEREST MANAGER HOLDING SCA
		
	By:	 	 /s/ Francois Dekker

		
	Name:	 	 Francois Dekker

		
	Title:	 	  

			
	Dated:	 	 17 June
	 	, 2010
	
	EXECUTIVE
	
	 /s/ Christopher D. Pappas

	Christopher D. Pappas

Employment Agreement Signature Page 

  

 EXHIBIT A 
 EQUITY AWARD TERM SHEET 
 The following summarizes the key terms of
certain incentive equity interests to be granted to Christopher D. Pappas (the “Executive”) in connection with the Executive’s proposed employment with Bain Capital Everest US Holding, Inc. (the “Company”)
following the consummation of the transactions contemplated by the Sale and Purchase Agreement by and among The Dow Chemical Company, Styron LLC, Styron Holding B.V. and STY Acquisition Corp., dated as of March 2, 2010 (the
“Transaction”). This term sheet forms a part of the Employment Agreement among the Executive, the Company and Bain Capital Everest Manager Holding SCA (“Luxco”), dated as of June 17, 2010 (the
“Employment Agreement”). The terms and conditions of the definitive documents relating to the Executive’s equity interests in Luxco which are executed at or about the Effective Date (the “Definitive Documents”)
shall supersede and replace this Exhibit A; provided that the following agreement shall survive execution of the Definitive Documents: Executive’s co-investment in Luxco shall be at the same price paid by Dow Europe Holding BV (an indirect
subsidiary of The Dow Chemical Company) in respect of its investment (the “Dow Investment”) made on or about the Closing (as defined below), and pursuant to terms and conditions that are no less favorable in all material respects
than those applicable to the Dow Investment immediately after it is made. 
  

			
	Co-Investment	  	 •      Upon the consummation of the Transaction (the “Closing”), the
Executive will co-invest in Luxco for the same securities to be held by “Bain” (as defined below), at the same price, and pursuant to the same terms and conditions, as is applicable to the Bain coinvestors, in the amount of $1,000,000
through the Executive’s issuance of a full recourse note to Luxco, bearing interest at the short-term applicable Federal rate as of the date of issuance, prepayable without penalty, and due December 31, 2010.

	
	Incentive Equity Grant
		
	 Form
	  	 •      Upon the Closing, the Executive will be granted one or more securities, or interests
in one or more securities (the “Award”), that will be intended to qualify as “profits interests” for U.S. tax purposes within the meaning of Revenue Procedures 93-27 and 2001-43, representing the right to participate in
2.5% of the post-Closing profits and capital appreciation of Luxco upon receipt by Bain Capital Partners, LLC and any private equity fund or collective or individual account managed by Bain Capital Partners, LLC or any of its affiliates
(collectively, “Bain”) of a return of its invested capital, excluding any interest or yield (whether or not preferred) on such invested capital. Such security or interest may consist of ordinary shares, preferred equity certificates
or convertible preferred equity certificates.

		
	 Vesting
	  	 •      Time Component: 75% of the Award will have
a time-vesting component, pursuant to which 25% thereof will be time-vested on a cliff basis on the first anniversary of the Closing with the balance time vesting ratably on a quarterly basis over the following three years.

 

•      Performance Component: 25% of the Award will have a
performance-vesting component, which will be satisfied if and when Bain obtains a 2.0 times return on its original equity capital investment (e.g., if Bain invests $700 million of equity capital in the Transaction, this component will be
satisfied if and when Bain receives back an aggregate (either actual receipt or, pursuant to the following sentence, deemed receipt) of $1.4 billion). For this purpose, return on capital investment will be measured on a “Change in Control”
and the “IPO” (each, as

  
 A-1

			
		  	 defined below) and will take into account distributions and/or sales proceeds received at or prior to the applicable determination date and the
residual value of Bain’s equity stake based on the value implied from the applicable transaction.

		
		  	 •      Accelerated Vesting: The time-vesting component of the Award will be deemed
fully satisfied upon a Change in Control that is not an IPO.

		
		  	 •      Termination of Employment:

		
		  	 •      Cause: The vested and unvested portion of the time-based component and the
performance-based component of the Award will be automatically cancelled and forfeited upon a termination by the Company for “Cause” (as defined below).

		
		  	 •      Without Good Reason. The unvested portion of the time-based component and the
performance-based component of the Award will be automatically cancelled and forfeited upon a termination by the Executive without “Good Reason” (as defined below). The Executive shall retain the Executive’s rights to the portion of
the time-based component of the Award that previously became vested in accordance with the vesting schedule above, subject to the securityholder rights described below.

		
		  	 •      Accelerated Vesting: If the Executive is terminated by the Company without
Cause or the Executive terminates employment for Good Reason, or on account of death or “Disability” (as defined below), (i) the Executive will receive 12 months of additional service credit with respect to the time-vesting component of
the Award, and (ii) any portion of the Award for which the time-vesting component has been satisfied (after taking into account the preceding clause (i)) and which also is subject to the performance-vesting component shall remain outstanding for the
12-month period following such termination and either (A) become fully vested when and if the performance-vesting component is attained during that period, or (B) be forfeited at the end of that period if the performance-vesting component is not
attained during that period. The unvested portion of the Award (after application of the previous sentence) will be forfeited.

		
		  	 •    Definitions:

		
		  	 •      The terms “Cause,” “Change in Control,”
“Disability,” and “Good Reason” will have the meanings set forth in the Employment Agreement.

		
		  	 •      Initial Public Offering (“IPO”): The term “Initial
Public Offering” will mean the first sale of Luxco’s equity interests, or the equity interests of any other entity for which Luxco’s equity interests are converted, substituted, sold or exchanged, to the public pursuant to an
effective registration statement under the Securities Act of 1933, as amended, or other applicable law.

		
	 83(b) Election
	  	 •      The Executive will make an 83(b) election within 30 days of grant of the Award
consistent with Revenue Procedures 93-27 and 2001-43 and any other official guidance promulgated thereafter.

  
 A-2

			
	 Restrictive Covenants
	  	 •      Employment Agreement. The restrictive
covenant provisions contained in the Employment Agreement will apply to the Award.
  
 •      Forfeiture on Material Breach: In the event of a “Material Covenant Violation” or a “Material Cooperation Violation” (each, as defined
in the Employment Agreement), the outstanding unvested portion of the Award will be forfeited and securities that became vested during the 6-month period preceding such Material Covenant Violation or Material Cooperation Violation will also be
forfeited.

		
	 Fair Market Value
	  	 •      Fair Market Value (“FMV”) will be initially determined by the Board
of Managers of Luxco (the “Board”) in good faith, without discounts for lack of marketability or minority interest. If the Executive wishes to challenge the valuation, the Executive may retain a nationally recognized firm experienced in
the valuation of private companies (the “Executive Valuator”) to determine FMV. If the Board and the Executive do not agree on FMV after the Executive Valuator’s FMV is presented to the Board, the Executive and the Board shall
agree on an independent nationally recognized firm experienced in the valuation of private companies (the “Independent Valuator,” which may not be the Executive Valuator), which shall determine FMV as either the number originally
presented to the Executive by the Board, or the number presented to the Board by the Executive Valuator. The FMV determined by the application of the process described above shall be the FMV for all purposes hereunder. If the final FMV, as
determined pursuant to the process described above, is 110% or more of the FMV originally determined by the Board, then Luxco or the Company will pay the cost of the Executive Valuator and, if applicable, the Independent Valuator, and if such final
FMV is less than 110% of the FMV originally determined by the Board, then the Executive will pay the cost of the Executive Valuator and, if applicable, the Independent Valuator. Notwithstanding the above, in choosing the Independent Valuator, if
applicable, the Board and the Executive shall take into account the cost thereof, with a view of retaining a firm which charges not more than $200,000 for such valuation.

	
	Securityholder Rights
		
	 Call Rights
	  	 •      Luxco will have a FMV call right upon any termination of employment (or upon vesting
of any portion of the performance-based component of the Award that becomes vested following termination of employment as provided above) for the vested portion of the Award which must be exercised, if at all, within 180 days following such
termination of employment (or following vesting, with respect to any portion of the performance-based component of the Award that becomes vested following termination of employment as provided above). The call price shall be payable in a single cash
lump sum no later than the later of (i) the 180th day
following termination of employment (or following vesting, with respect to any portion of the performance-based component of the Award that becomes vested following termination of employment as provided above), and (ii) the 10th day following the determination of FMV pursuant to the dispute
resolution mechanism described above in “Fair Market Value.”

		
	 Tag-Along Rights
	  	 •      If Bain intends to sell to a third party more than 20% of its aggregate holdings in
Luxco, other than in respect of a sale by Bain of a portion of its holdings to another entity which is otherwise included in the definition of “Bain” hereunder, or to employees or directors of Luxco or its directly or indirectly
majority-owned subsidiaries, the Executive will be entitled to participate on a pro-rata basis with Bain in such transaction in respect of the vested portion of the Award under

  
 A-3

			
		  	 terms and conditions no less favorable than those which apply to Bain, so long as the Executive takes all customary necessary or desirable actions
as reasonably requested by Bain in connection therewith (including executing and delivering definitive agreements with respect thereto).

		
	 Drag-Along Rights
	  	 •      The Executive will be subject to drag-along rights in favor of (and will take such
customary actions reasonably requested by) Bain and/or Luxco if the Board or Bain approves a sale of Luxco (whether by merger, consolidation, sale of assets, sale of equity, public offering or otherwise) (an “Approved Sale”). In the
event of an Approved Sale, the Executive will consent to and raise no objections against such Approved Sale, waive all dissenters’ rights, appraisal rights or similar rights, and, in the event of a sale of all of Luxco’s equity held by
persons other than the Executive, will agree to sell all of the Executive’s interests (whether acquired in connection with the Closing or thereafter) on terms and conditions no less favorable than those which apply to any other seller and take
all customary necessary or desirable actions (including executing all agreements and documents) in connection with the consummation of the Approved Sale as reasonably requested by the Luxco or Bain.

		
	 Registration Rights
	  	 •      The Award will be subject to market piggyback
registration rights provisions for interests held by the Executive, provided that no registration rights will apply to securities acquired pursuant to an incentive award in connection with any underwritten offering that includes a secondary sale of
shares.
  

•      In connection with an IPO, all securities held by the Executive will be
converted into an equivalent value of the securities to be offered to the public in the IPO and such securities will be registered on Form S-8, if available.

		
	 Transfer Restrictions
	  	 •      No portion of the Award (or the underlying securities) is transferable without the
prior written approval of Luxco, which may be granted or withheld in its sole discretion (other than among the Executive’s family group, to Luxco, Bain or their designees in connection with a termination of employment, or in connection with the
Drag-Along or Tag-Along Rights described above).

		
	 Impact of the IPO
	  	 •      Upon and following an IPO, the Call Rights, Tag-Along Rights, Drag-Along Rights and
Transfer Restrictions will cease to apply.

		
	 Joinder
	  	 •      The Executive will execute and deliver either a counterpart or a joinder to any
applicable securityholders agreement and/or any other agreements governing the terms of the equity interests in Luxco; provided that no such agreement may provide the Executive with less favorable rights in any manner than those described in this
term sheet, or impose significant restrictions in addition to those described in this term sheet on the Executive’s right to acquire, hold and dispose of the equity interests represented by the Award.

		
	 Cooperation; Further Assurances
	  	 •      Bain and the Executive shall cooperate with each other prior to the Closing and do,
or procure the doing of, all acts and things, and execute, or procure the execution of, all documents, as may reasonably be required to give full effect to this term sheet.

  
 A-4

 EXHIBIT B 
 RETIREMENT BENEFITS SCHEDULE 
 The Company shall provide the
Executive with a retirement benefit on the following terms and conditions: 
  

	 	•	 	 Vesting: Subject to the last sentence of Section 6(c) of the Agreement, the Executive shall be fully vested in the “Accrued
Benefit” (as defined below). 

  

	 	•	 	 Payment: Subject to the last sentence of Section 6(c) of the Agreement, the Accrued Benefit will be paid in a cash lump sum promptly after
any termination of employment. 

  

	 	•	 	 Accrued Benefit: The Executive’s Accrued Benefit will be equal to the following formula: 

(Basic Percentage x Final Average Pay) + (Supplemental Percentage x Adjusted Final Average Pay) 

 

	 	•	 	 Definitions: 

  

	 	•	 	 Basic Percentage: The Executive’s Basic Percentage will be the applicable Basic Percentage determined pursuant to the table below based on
the aggregate Years of Service Credit credited to the Executive at his date of termination: 

  

					
	 Aggregate Years of

Service Credit
	  	Total Basic Percentage	 
	 6
	  	 	138	% 
	 12
	  	 	276	% 
	 18
	  	 	414	% 
	 24
	  	 	425	% 
	 30
	  	 	425	% 

 In no event may the
Executive’s Basic Percentage exceed 425%. 
  

	 	•	 	 Supplemental Percentage: The Executive’s Supplemental Percentage will be the applicable Supplemental Percentage determined pursuant to the
table below based on the aggregate Years of Service Credit credited to the Executive at his date of termination: 

  

					
	 Aggregate Years of

Service Credit
	  	Total Supplemental
Percentage	 
	 6
	  	 	24	% 
	 12
	  	 	48	% 
	 18
	  	 	72	% 

  
 B-1

					
	 24
	  	 	96	% 
	 30
	  	 	120	% 

 In no event may the
Executive’s Supplemental Percentage exceed 120%. 
  

	 	•	 	 Final Average Pay: The Executive’s Final Average Pay shall equal the average of the sum of the Executive’s Base Salary and Target
Bonus for the three full calendar years preceding his termination of employment for any reason (or such smaller number of full calendar years that the Executive has worked as of his date of termination or, if such termination occurs before the
Executive has been employed with the Company for at least one full calendar year, the Base Salary and Target Bonus in effect at the time of termination). 

 

	 	•	 	 Adjusted Final Average Pay: The Executive’s Adjusted Final Average pay shall equal the Executive’s Final Average Pay reduced by the
36-month rolling average Social Security Taxable Wage Base as of the Executive’s date of termination for any reason calculated in a manner consistent with the “DEPP” component of the Dow Employees’ Pension Plan as in effect on
the date hereof. 

  

	 	•	 	 Years of Service Credit: The number of Years of Service Credit credited to the Executive pursuant to Section 6(c) of the Agreement.

  

	 	•	 	 Examples: 

  

	 	•	 	 Assume the Executive is employed by the Company on the fourth anniversary of the Effective Date, his Final Average Pay is equal to $1.7 million and his
Adjusted Final Average Pay is $1.6 million. If the Executive terminated on that date, his Accrued Benefit would equal $9,145,000 (i.e., 425% of $1.7 million plus 120% of $1.6 million). 

 

	 	•	 	 Assume the Executive is employed by the Company on the first anniversary of the Effective Date, his Final Average Pay is equal to $1.6 million and his
Adjusted Final Average Pay is $1.5 million. If the Executive terminated on that date, his Accrued Benefit would equal $5,136,000 (i.e., 276% of $1.6 million plus 48% of $1.5 million). 

  
 B-2

 EXHIBIT C 
 SECTION 280G PROVISIONS 
 This Exhibit C sets forth the terms and
provisions applicable to the Executive pursuant to the provisions of Section 8 of the Agreement. This Exhibit C shall be subject in all respects to the terms and conditions of the Agreement. Capitalized terms used without definition in this
Exhibit C shall have the meanings set forth in the Agreement. 
  

	1.	Change in Control Prior to Publicly Traded Equity of Company. So long as the Company is described in Section 280G(b)(5)(A)(ii)(l) of the Code, in the event
that any payment that is either received by the Executive or paid by the Company on the Executive’s behalf or any property, or any other benefit provided to the Executive under the Agreement or under any other plan, arrangement or agreement
with the Company or any other person whose payments or benefits are treated as contingent on a change of ownership or control of the Company (or in the ownership of a substantial portion of the assets of the Company) or any person affiliated with
the Company or such person (but only if such payment or other benefit is in connection with the Executive’s employment by the Company) (collectively the “Company Payments”), would be subject to the tax imposed by
Section 4999 of the Code (and any similar tax that may hereafter be imposed by any taxing authority) (the “Excise Tax”), the Company shall, with respect to such Company Payments, use its reasonable best efforts to obtain a vote
satisfying the requirements of Section 280G(b)(5) of the Code, such that no portion of the Company Payments will be subject to such Excise Tax. In the event that a vote satisfying the requirements of Section 280G(b)(5) of the Code is not
obtained for any reason, then the Executive will be entitled to receive a portion of the Company Payments having a value equal to $1 less than three (3) times the Executive’s “base amount” (as such term is defined in
Section 280G(b)(3)(A) of the Code). Any reduction of the Company Payments pursuant to the foregoing shall occur in the following order: (i) any cash severance payable by reference to the Executive’s base salary or annual bonus;
(ii) any other cash amount payable to the Executive; (iii) any benefit valued as a “parachute payment;” and (iv) acceleration of vesting of any equity award. 

 

	2.	Change in Control Upon or Following Publicly Traded Equity of Company. In the event that Company Payments become payable to the Executive during any period in
which the Company is not described in Section 280G(b)(5)(A)(ii)(I) of the Code, the following shall apply: 

  

	 	(a)	In the event that such Company Payments will be subject to the Excise Tax, the Company shall pay to the Executive an additional amount (the “Gross-Up
Payment”) such that the net amount retained by the Executive, after deduction of any Excise Tax on the Company Payments and any U.S. federal, state, and local income or payroll tax upon the Gross-Up Payment provided for by this clause 2(a),
but before deduction for any U.S. federal, state, and local income or payroll tax on the Company Payments, shall be equal to the Company Payments. 

  
 C-1

	 	(b)	For purposes of determining whether any of the Company Payments and Gross-Up Payment (collectively, the “Total Payments”) will be subject to the Excise
Tax and the amount of such Excise Tax, (i) the Total Payments shall be treated as “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and all “parachute payments” in excess of the “base
amount” (as defined under Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the opinion of the Company’s independent certified public accountants appointed prior to
any change in ownership (as defined under Section 280G(b)(2) of the Code) or tax counsel selected by such accountants or the Company (the “Accountants”) such Total Payments (in whole or in part) are not subject to the Excise
Tax, and (ii) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants in accordance with the principles of Section 280G of the Code. In the event that the Accountants are serving as
accountants or auditors for the individual, entity or group effecting the change in control (within the meaning of Section 280G of the Code), the Company shall appoint another nationally recognized accounting firm to make the determinations
hereunder (which accounting firm shall then be referred to as the “Accountants” hereunder). All determinations hereunder shall be made by the Accountants, who shall provide detailed supporting calculations both to the Company and the
Executive at such time as it is requested by the Company or the Executive. The determination of the Accountants shall be final and binding upon the Company and the Executive. 

 

	 	(c)	For purposes of determining the amount of the Gross-Up Payment, the Executive’s marginal blended actual rates of federal, state and local income taxation in the
calendar year in which the change in ownership or effective control that subjects the Executive to the Excise Tax occurs shall be used. In the event that the Excise Tax is subsequently determined by the Accountants to be less than the amount taken
into account hereunder at the time the Gross-Up Payment is made, the Executive shall promptly repay to the Company, at the time that the amount of such reduction in Excise Tax is finally determined, the portion of the prior Gross-Up Payment
attributable to such reduction (plus the portion of the Gross-Up Payment attributable to the Excise Tax and U.S. federal, state and local income tax imposed on the portion of the Gross-Up Payment being repaid by the Executive), plus interest on the
amount of such repayment at the rate provided in Section 1274(b)(2)(B) of the Code. In the event that the Excise Tax is later determined by the Accountants or the Internal Revenue Service to exceed the amount taken into account hereunder at the
time the Gross-Up Payment is made (including by reason of any payment the existence or amount of which cannot be determined at the time of the Gross-Up Payment), the Company shall make an additional Gross-Up Payment in respect of such excess (plus
any interest or penalties payable with respect to such excess imposed by the applicable taxing authority) promptly after the amount of such excess is finally determined. 

 

	 	(d)	 The Gross-Up Payment or portion thereof provided for in clause 2(c) above shall be paid not later than the sixtieth (60th) day following an event
occurring which subjects the Executive to the Excise Tax; provided, however, that if the amount of 

  
 C-2

	 	 
such Gross-Up Payment or portion thereof cannot be finally determined on or before such day, the Company shall pay to the Executive on such day an estimate, as determined in good faith by the
Accountants, of the minimum amount of such payments and shall pay the remainder of such payments (together with interest at the rate provided in Section 1274(b)(2)(B) of the Code), subject to further payments pursuant to clause 2(c) above, as
soon as the amount thereof can reasonably be determined. Subject to clauses 2(c) and 2(h) of this Exhibit C, in the event that the amount of the estimated payments exceeds the amount subsequently determined to have been due, such excess shall
constitute a loan by the Company to the Executive, payable on the fifth (5th) day after demand by the Company (together with interest at the rate provided in Section 1274(b)(2)(B) of the Code). 

 

	 	(e)	The Executive shall promptly notify the Company in writing of any claim by any taxing authority that, if successful, would require the payment by the Company of a
Gross-Up Payment; provided, however, that failure by the Executive to give such notice promptly shall not result in a waiver or forfeiture of any of the Executive’s rights under this Exhibit C except to the extent of actual
damages suffered by the Company as a result of such failure. If the Company notifies the Executive in writing within 15 days after receiving such notice that it desires to contest such claim (and demonstrates to the reasonable satisfaction of the
Executive its ability to pay any resulting Gross-Up Payment), the Executive shall: 

  

	 	(i)	give the Company any information reasonably requested by the Company relating to such claim; 

 

	 	(ii)	take such action in connection with contesting such claim as the Company shall reasonably request in writing from time to time, including, without limitation, accepting
legal representation with respect to such claim by an attorney selected by the Company that is reasonably acceptable to the Executive; 

  

	 	(iii)	cooperate with the Company in good faith in order effectively to contest such claim; and 

 

	 	(iv)	permit the Company to participate in any proceedings relating to such claim; 

 provided, however, that the Company’s actions do not unreasonably interfere with or prejudice Executive’s disputes with the taxing authority as to other issues; and
provided, further, that the Company shall bear and pay on an after-tax and as-incurred basis, all attorneys fees, costs and expenses (including additional interest, penalties and additions to tax) incurred in connection with such
contest (including but not limited to those of the Executive’s personal counsel) and shall indemnify and hold the Executive harmless, on an after-tax and as-incurred basis, for all resulting taxes (including, without limitation, income and
excise taxes), interest, penalties and additions to tax. 

  
 C-3

	 	(f)	The Company shall be responsible for all charges of the Accountants. 

  

	 	(g)	The Company and the Executive shall promptly deliver to each other copies of any written communications, and summaries of any verbal communications, with any taxing
authority regarding the Excise Tax covered by this Exhibit C. 

  

	 	(h)	Nothing in this Exhibit C is intended to violate the Sarbanes-Oxley Act of 2002 and to the extent that any advance or repayment obligation hereunder would do so, such
obligation shall be modified so as to make the advance a nonrefundable payment to the Executive and the repayment obligation null and void. 

  

	 	(i)	Notwithstanding the foregoing, any payment or reimbursement made pursuant to this clause 2 shall be paid to the Executive promptly and in no event later than the end of
the calendar year next following the calendar year in which the related tax is paid by the Executive or as otherwise provided under Treasury Regulation §1.409A-3(i)(l)(v). 

 

	3.	The provisions of this Exhibit C shall survive the termination of the Executive’s employment with the Company for any reason and any amount payable under this
Exhibit C shall be subject to the provisions of Sections 8(e) and 24 of the Agreement. 

  
 C-4

 EXHIBIT D 
 GENERAL RELEASE 
 I, Christopher D. Pappas, in consideration of and
subject to the performance by Bain Capital Everest US Holding, Inc. (together with its subsidiaries, the “Company”), of its obligations under the Employment Agreement, dated as of June 17, 2010 (the
“Agreement”), do hereby release and forever discharge as of the date hereof the Company and its respective “Affiliates” (as defined in the Agreement) and all present, former and future directors, officers, employees,
successors and assigns of the Company and its Affiliates and direct or indirect owners (collectively, the “Released Parties”) to the extent provided below. The Released Parties are intended third-party beneficiaries of this General
Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. Terms used herein but not otherwise defined shall have the meanings given to
them in the Agreement. 
 1. I understand that any payments or benefits paid or granted to me under Section 8 of the Agreement represent,
in part, consideration for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain of the payments and benefits specified in Section 8 of the
Agreement unless I execute this General Release and do not revoke this General Release within the time period permitted hereafter. Such payments and benefits will not be considered compensation for purposes of any employee benefit plan, program,
policy or arrangement maintained or hereafter established by the Company or its affiliates. 
 2. Except as provided in paragraphs 4 and 5 below
and except for the provisions of the Agreement which expressly survive the termination of my employment with the Company, I knowingly and voluntarily (for myself, my heirs, executors, administrators and assigns) release and forever discharge the
Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages,
claims for costs and attorneys’ fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date this General Release becomes effective and enforceable) and whether known or unknown, suspected, or
claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors, administrators or assigns, may have, which arise out of or are connected with my employment with, or my separation or termination from, the
Company (including, but not limited to, any allegation, claim or violation, arising under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including
the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement
Income Security Act of 1974; any applicable Executive Order Programs; the Fair Labor Standards Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or
federal law, regulation or ordinance; or under any public policy, contract or tort, or under common law; or arising under any policies, practices or procedures of the 

  
 D-1

 
Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including attorneys’ fees
incurred in these matters) (all of the foregoing collectively referred to herein as the “Claims”). 
 3. I represent that I
have made no assignment or transfer of any right, claim, demand, cause of action, or other matter covered by paragraph 2 above. 
 4. I agree
that this General Release does not waive or release any rights or claims that I may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute this General Release. I acknowledge and agree that my separation
from employment with the Company in compliance with the terms of the Agreement shall not serve as the basis for any claim or action (including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). 

5. I agree that I hereby waive all rights to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind whatsoever
in respect of any Claim, including, without limitation, reinstatement, back pay, front pay, and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that
cannot be waived under law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim and waive any right to share or participate in any monetary award
resulting from the prosecution of such charge or investigation or proceeding. Additionally, I am not waiving any right to the Accrued Benefits or claims for indemnity or contribution. 
 6. In signing this General Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims hereinabove mentioned or implied. I expressly consent that this General
Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected Claims (notwithstanding any state or local statute that expressly limits the
effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned or implied. I acknowledge and agree that this waiver is an essential and material term
of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim seeking damages against the Company, or in the event I should seek to
recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent permitted by law. I further agree that I am not aware of any pending
claim of the type described in paragraph 2 as of the execution of this General Release. 
 7. I agree that neither this General Release, nor the
furnishing of the consideration for this General Release, shall be deemed or construed at any time to be an admission by the Company, any Released Party or myself of any improper or unlawful conduct. 

8. I agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses of defending
against the suit incurred by the Released Parties, including reasonable attorneys’ fees. 

  
 D-2

 9. I agree that this General Release and the Agreement are confidential and agree not to disclose any
information regarding the terms of this General Release or the Agreement, except to my immediate family and any tax, legal or other counsel I have consulted regarding the meaning or effect hereof or as required by law, and I will instruct each of
the foregoing not to disclose the same to anyone. The Company agrees to disclose any such information only to any tax, legal or other counsel of the Company as required by law. 
 10. Any non-disclosure provision in this General Release does not prohibit or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and
circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization or any governmental entity. 
 11. I hereby acknowledge that Sections 8, 9, 10, 11, 12, 14, 16, 18, 19, 20, 21, and 24, and Exhibits A, B and C, of the Agreement shall survive my execution of this General Release. 

12. I represent that I am not aware of any claim by me other than the claims that are released by this General Release. I acknowledge that I may
hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or suspected at the time of entering
into this General Release, may have materially affected this General Release and my decision to enter into it. 
 13. Notwithstanding anything
in this General Release to the contrary, this General Release shall not relinquish, diminish, or in any way affect any rights or claims arising out of any breach by the Company or by any Released Party of the Agreement after the date hereof.

 14. Whenever possible, each provision of this General Release shall be interpreted in, such manner as to be effective and valid under
applicable law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any
other provision or any other jurisdiction, but this General Release shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. 

BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: 
  

	 	1.	I HAVE READ IT CAREFULLY; 

  

	 	2.	I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF
1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED; 

 

	 	3.	I VOLUNTARILY CONSENT TO EVERYTHING IN IT; 

  
 D-3

	 	4.	I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL READING AND CONSIDERATION I HAVE CHOSEN NOT TO DO SO OF MY OWN
VOLITION; 

  

	 	5.	I HAVE HAD AT LEAST [21][45] DAYS FROM THE DATE OF MY RECEIPT OF THIS RELEASE TO CONSIDER IT AND THE CHANGES MADE SINCE MY RECEIPT OF THIS RELEASE ARE NOT MATERIAL OR
WERE MADE AT MY REQUEST AND WILL NOT RESTART THE REQUIRED [21][45]-DAY PERIOD; 

  

	 	6.	I UNDERSTAND THAT I HAVE SEVEN (7) DAYS AFTER THE EXECUTION OF THIS RELEASE TO REVOKE IT AND THAT THIS RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE
REVOCATION PERIOD HAS EXPIRED; 

  

	 	7.	I HAVE SIGNED THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT TO IT; AND 

 

	 	8.	I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED
REPRESENTATIVE OF THE COMPANY AND BY ME. 

  

									
	SIGNED:	 	  
	 		 	DATED:	 	  

		 	Christopher D. Pappas	 		 		 	

  
 D-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]